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The catabolic degradation of proteins is vital for the proper function and homeostasis 
of all cells.  Autophagy is one of the major catabolic systems, and it is involved in 
processes that are as diverse as cell survival, cell death, immune reaction, cancer and 
neurodegeneration.  Neurodegenerative diseases often have the pathology of protein 
accumulation in inclusions, but it is unclear whether these inclusions cause cell 
toxicity.  Here I show that autophagy has protective functions in a model of a 
polyglutamine neurodegenerative disease in Drosophila.  Inhibition of autophagy in 
this model enhances polyglutmine-induced degeneration, while activation of 
autophagy suppresses degeneration.  Moreover, I observed similar protein aggregates 
in the larval salivary glands of a Drosophila dynein light chain mutant.  This dynein 
 
 
light chain mutant is defective in autophagy, and their salivary glands fail to execut  
developmentally regulated programmed cell death.  Ectopic activation of autophagy 
is sufficient to suppress the protein accumulation in dynein light chain mutant 
salivary glands.  Both neurons and salivary glands are long-lived post-mitotic cells, 
and these cells are likely to have unique catabolic needs.  Our data indicate that 
defects in catabolism are responsible for the neurodegenerative and salivary gland 
cell death defects that I observed, and could explain the association of autophagy wit  
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Neurodegenerative disease refers to a pathological condition that primarily affects 
neurons and causes neuronal dysfunction and neuronal death.   These disorders most 
commonly arise in the elderly for no apparent reason, and progress in a relentless 
manner.  Diseases of the nervous system combined account for more suffering and 
care than all other diseases (Cowan and Kandel 2001).  In addition, as the prevalence 
of elderly people increases in society, the frequency and burden of these diseases 
increases.    
Classification and diagnosis of the neurodegenerative diseases have been difficult 
because of overlapping symptoms.  In practice, many diseases are classified by 
referencing their founder’s name, such as Alzheimer’s disease.  Pathologically, the 
affected areas of the central nervous system have been used (Przedborski, Vila et al. 
2003).  For example, neurodegenerative diseases are classified to affect the c rebral 
cortex, the basal ganglia, the brain stem, cerebellum and the spinal cord, such as
Spinobulbar Muscular Atrophy.  Diseases of the cerebral cortex, such as in 
Alzheimer’s disease, result in symptoms including memory loss and confusion (i.e.  
dementia) (Martin 1999).  Diseases that predominately affect basal ganglia s in 
Parkinson’s disease are characterized by involuntary movements (Nussbaum and Ellis 
2003).  Diseases of the brain stem, cerebellum and the spinal cord, such as 
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amyotrophic lateral sclerosis (ALS), commonly cause muscular atrophy and in bility 
to move (Table 1).  In recent years, elucidation of molecular basis of 
neurodegenerative diseases led to new classification systems.  For instance, the terms 
“tri-nucleotide repeat disorders” and “polyglutamine expansion diseases” were 
introduced with the discovery of mutations that are caused by expansion of repeat 
regions in causative genes (Orr and Zoghbi 2007).   
The factors that cause neurodegenerative diseases are not completely clear.  
Relatively small numbers of diseases, like the polyglutamine expansion diseases, 
have purely genetic causes; some are purely sporadic and others seem to be caused by 
both genetic and environmental factors.  Certain types of neurodegenerative diseases 
are observed in particular geographical locations.  For example, a type of ALS and 
Parkinson’s disease (PD) combination (Guam-ALS) is observed in specific islands of 
Guam, and is associated with consumption of an indigenous plant species (Spencer, 
Nunn et al. 1987).  In addition, exposure to a neurotoxin that is a side product of the 
analgesic drug meperidine synthesis is known to cause symptoms identical to 
Parkinson’s disease (Bove, Prou et al. 2005).  These examples suggest that 
neurodegenerative diseases can be caused by purely environmental factors.  
Investigation of genetic causes of these and other diseases is underway.  The most 
common form of motor neuron degeneration, ALS, is caused by a dominant mutation 
in the superoxide dismutase (SOD) gene, but this only occurs in 2% of the reported 
cases (Rosen, Siddique et al. 1993).  The causes of the rest of the cases are not 
known, but mutations in the dynein heavy chain in mouse models have been reported 
to cause ALS symptoms as well (Hafezparast, Klocke et al. 2003; Chen, Levedakou 
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et al. 2007).  The most common neurodegenerative disorder, Alzheimer’s disease, is 
caused by an autosomal dominant mutation in the amyloid precursor protein in 3-5% 
of reported cases.  Although other mutations have been reported (Nussbaum and Ellis 
2003), the cause of the majority of the cases is still unknown.  The prevalence of 
Alzheimer’s disease among those 65 to 69 years of age is 1%, and  increases to 40-
50% among people 95 years of age or older (Hy and Keller 2000).  This implies that 
environmental or intrinsic causes that accumulate with age may increase 
predisposition to disease.  Similarly, only a small fraction of all Parkinson’s disease 
cases are linked to genetic mutations (Nussbaum and Ellis 2003).   
In spite of their differences, most of the neurodegenerative diseases are 
characterized by protein inclusion formation in affected areas of the nervous system.  
This common observation led to the hypothesis that neurodegenerative diseases might 
share a common mechanism of pathology.  Alzheimer’s disease has been associated 
with two major kinds of inclusions.  Extracellular inclusions are derived from the 
amyloid precursor protein (APP), and form β-sheet structures called “amyloids”.  
Intracellular inclusions are formed by the microtubule-associated protein Tau (Hardy 
and Selkoe 2002).  Parkinson’s disease pathology is characterized by the formation of 
the Lewy bodies, which are protein inclusions with α-synuclein being the major 
constituent (Gai, Blessing et al. 1995).  In ALS, surviving motor neurons develop 
protein inclusions called Bonina bodies that stain positive for SOD1 (Bruijn, 
Houseweart et al. 1998; Hafezparast, Klocke et al. 2003).  Moreover, polyglutamine 
expansion diseases, such as Huntington’s disease, are all associated with protein 
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inclusion formation (Zoghbi and Orr 2000).  Studies of this common pathology may 
prove beneficial in understanding neurodegenerative diseases.   
Polyglutamine expansion diseases 
Polyglutamine expansion diseases are a group of progressive genetic diseases that 
are caused by increase in the number of naturally occurring CAG triplet (encoding 
glutamine) repeats in certain genes (Table 1).  The number of CAG repeats is normal 
below approximately 40 repeats, but above this threshold neurodegenerative diseas 
ensues.  These diseases are inherited in a dominant fashion, which implies a gain of 
function effect of CAG expansion (La Spada and Taylor 2003).  The significance of 
having CAG repeats in some genes is not known.  The number of CAG repeats in 
normal alleles of causative genes are highly variable, and they can be as little4 
CAG repeats in Huntingtin (Htt) in some species (Harjes and Wanker 2003).  
Therefore, having CAG repeat expansion may have little functional relevance to the 
protein.  Whether expansion of CAG repeats alone causes neurodegeneration is a 
subject of debate (Orr and Zoghbi 2007).  When only the first exon of the htt g ne, 
which contains the polyglutamine stretch, is expressed in mice it causes 
neurodegeneration that is similar to Huntington disease (HD) (Mangiarini, 
Sathasivam et al. 1996).  The CAG expansion in the androgen receptor (AR) that 
results in spinobulbar muscular atrophy (SBMA) does not cause loss of function of 
AR, since patients do not show many symptoms of testicular feminization (Doyu, 
Sobue et al. 1992).  Moreover, deletion of AR in humans does not cause any 
symptoms of neurodegeneration (Brown, Lubahn et al. 1988; Brinkmann 2001).  
These examples support a model in which expansion of CAG itself causes the disease 
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and not changes in the function of the protein.  Although its function is unknown, Htt 
has been suggested to be involved in vesicular transport along the axon tracts 
(Gunawardena, Her et al. 2003).  This could fit a model where changes in the protein 
function lead to neurological dysfunction (discussed further below).   
Models of polyglutamine expansion diseases 
Polyglutamine expansion diseases are particularly well suited to model in animals 
due to their characterized mutations and dominant genetic nature.  Models have been 
created in worms, flies, mice and non-human primates.  Creation of these models has 
utilized either ectopic expression of expanded form of the causative protein by 
providing it in trans or by stable insertion of the gene into the genome.  The HD 
models in C. elegans have been created by ectopic expression of expanded form of 
the first exon of Htt.  Expression of 88, 128 or 150 glutamine repeats in the first exon 
resulted in impaired neuronal function in a length-dependent fashion (Faber, Alter et 
al. 1999; Parker, Connolly et al. 2001).  In addition, ectopic expression of a 
polyglutamine stretch fused with GFP caused neurodegeneration with visible GFP 
punctate inclusions (Satyal, Schmidt et al. 2000).  This shows that expression of 
expanded glutamine alone can recapitulate disease phenotype in C.  legans.  
Moreover, the convenience of RNAi screening methods and advancements in aging 
research in C.  elegans have facilitated investigation of genetic modifiers of 
neurodegeneration in a model that expressed glutamine stretches alone (Brignull, 
Morley et al. 2006).    
Drosophila is convenient for recapitulating polyglutamine expansion diseases due 
to its tissue specific expression tool, the UAS/GAL4 system (Brand and Perrimon 
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1993), and availability of various behavioral tests, including robust assays to measure 
motor activity.  Expanded polyglutamine-encoding genes can be cloned and 
expressed in either subsets of neurons, the entire nervous system or in the eye.  The 
fly eye has beneficial attributes for studying neurodegeneration, as it is not an 
essential organ and degeneration of cells can easily be evaluated based on the external 
structure of the eye.   Drosophila was the first organism in which a polyglutamine 
expansion disease spinocerebellar ataxia 3 (SCA3) was modeled (Warrick, Paulson et 
al. 1998).  Later HD, spinocerebellar ataxia 1 (SCA1) and spinobulbar muscular 
atrophy (SBMA) were also modeled in Drosophila (Jackson, Salecker et al. 1998; 
Fernandez-Funez, Nino-Rosales et al. 2000; Takeyama, Ito et al. 2002).  The strength 
of using Drosophila as a model organism was recently demonstrated by a model of 
SCA3, which led to a novel discovery in a genetic screen for modifiers of disease 
symptoms.  In this screen, the authors reported that, in addition to protein, ataxin-3 
mRNA itself caused some aspects of neurodegeneration (Li, Yu et al. 2008).  This 
finding implied that mRNAs may contribute to symptoms seen in the polyglutamine 
expansion diseases.   
All of the polyglutamine diseases have been modeled in mice (Marsh, 
Lukacsovich et al. 2008).  The first HD model in mice that recapitulated the disease 
symptoms was made by ectopic expression of an expanded glutamine first exon of
Htt.  In addition, knock-in models of HD were made in which glutamine repeat region 
of endogenous mouse htt was expanded by homologous recombination (Levine, 
Klapstein et al. 1999; Lin, Tallaksen-Greene et al. 2001).  Symptoms of 
neurodegeneration in these models were milder than ectopic expression models.  In 
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addition to HD models, SBMA mouse models were made by ectopic expression of 
polyglutamine-expanded full length or truncated AR (Bingham, Scott et al. 1995; 
Abel, Walcott et al. 2001).  Neurodegeneration was seen only in males, and castration 
reversed disease progression indicating the need for the ligand of androgen receptor 
(AR), testosterone, for disease onset.  Moreover, in a mouse model of SBMA 
hormone therapy with Leuprorelin that decreased release of testosterone, rversed 
SBMA symptoms (Katsuno, Adachi et al. 2003).  This example shows that mouse 
models can successfully be used to assess the outcomes of therapeutic agents.     
Recently a rhesus macaque model of HD expressing the first exon of Htt with 
various repeats of glutamine was developed using lentivirus as a gene delivery tool.  
These animals showed symptoms of HD including involuntary movements, 
swallowing and respiratory difficulty with pathology of inclusion formation in their 
brains (Yang, Cheng et al. 2008).  In the future, non-human primate models could be 
used to better assess the outcomes of therapeutic chemicals that are being considered 
for use in humans.    
Molecular Pathogenesis of polyglutamine expansion diseases 
Transcription factor deactivation 
Transcription factors are commonly found as part of the protein inclusions in 
degenerating cells and tissues in neurodegenerative diseases.  This led to the 
hypothesis that changes in gene expression due to sequestration of transcriptio  
factors could lead to the symptoms of neurodegeneration (Okazawa 2003).  CREB-
binding protein (CBP) has been reported in protein inclusions caused by numerous 
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mutant proteins, including Htt and AR (McCampbell, Taylor et al. 2000; Nucifora, 
Sasaki et al. 2001).  Although no direct evidence support this model, these results led 
to speculation that cell toxicity was caused either by titration or mislocalization of 
CBP.  Similarly, the transcription factor Sp1 unnaturally interacts with 
polyglutamine-expanded Htt in its soluble form, and Sp1’s transcriptional activity is 
repressed in early phases of HD, suggesting that repression of Sp1 could lead to some 
of the neurodegenerative symptoms (Dunah, Jeong et al. 2002).  Furthermore, it was 
suggested that polyglutamine-expanded Htt leads to repression of brain derived 
neurotrophic factor because Htt’s natural interaction with a transcription factor that 
activates neurotrophic factors is reduced (Zuccato, Tartari et al. 2003).  Since
neurotrophic factors are necessary for neuronal survival this could explain why 
neurons would be exclusively affected (Zweifel, Kuruvilla et al. 2005).   
Loss of mutant protein function        
Even though polyglutamine expansion diseases follow a dominant pattern of 
inheritance, it is possible that expansion of polyglutamine causes loss of natural 
protein function.  If this is the case, deletion of causative genes should lead to 
neurodegeneration.  Homozygous deletion of htt in mice is lethal (Duyao, Auerbach 
et al. 1995), and conditional htt knock-out caused progressive neurodegeneration in 
one report (Dragatsis, Levine et al. 2000).  Moreover, ectopic expression of wild type 
Htt rescues neurodegenerative symptoms in a HD model (Leavitt, Guttman et al. 
2001).  These examples demonstrate that loss of Htt function can lead to some of the 
HD phenotypes, perhaps due to its regulation of brain derived neurotrophic factor.  
Moreover, in a mouse model of SCA1, which is caused by mutation of Ataxin-1, 
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neurodegenerative symptoms were decreased by incorporation of an extra copy of 
wild type ataxin-1 into the genome (Bowman, Lam et al. 2007).  By contrast to these 
examples, other mouse models with deletion in htt or ataxin-1 did not result in 
neurodegenerative phenotypes (Duyao, Auerbach et al. 1995; Matilla, Roberson et al. 
1998).  In addition, homozygous HD patients have similar severity and progression of 
symptoms as heterozygous HD patients (Wexler, Young et al. 1987).  Collectively, i 
is not clear whether loss of mutant gene function is a factor in polyglutamine 
expansion diseases.       
Protein misfolding and protein stress 
 Expansion of polyglutamine beyond a threshold is likely to cause changes in 
protein structure.  Proteins with expanded polyglutamines were found to assume 
novel confirmations in cell lines (Welch and Diamond 2001).  Furthermore, in vitro 
experiments showed that proteins with polyglutamine expansions, unlike normal 
proteins, form a β-sheet dominated structure that results in toxicity once 
microinjected into cell lines (Nagai, Inui et al. 2007).  These data imply that 
expansion of polyglutamine renders the proteins susceptible to misfolding.  This 
could be one of the earlier events that eventually lead to protein inclusion formation 
and neurodegeneration.  Overexpression of heat shock chaperones Hsp40 and Hsp70  
was shown to ameliorate toxicity caused by expanded AR expression in cell lines 
(Kobayashi, Kume et al. 2000).  Therefore, it is likely that protein stress ensues i  
cells due to misfolded proteins.  Moreover, since, ubiquitin is very frequently found 
in protein inclusions of neurodegenerative disease samples, the ubiquitin-proteasome 
system could be involved in degradation of these proteins (Ross and Pickart 2004).   
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Proteasome inhibition and inclusion formation 
Proteins with expanded polyglutamine stretches cause neurodegenerative 
diseases with the pathology of inclusion formation (Ross and Poirier 2004).   The 
common observation that inclusions contain truncated forms of the polyglutamine 
expanded protein (Sieradzan, Mechan et al. 1999) led to the hypothesis that these 
proteins should initially be cleaved.  Caspase-3 and caspase-6 have been implicated in 
the initial cleavage of Htt (Graham, Deng et al. 2006).  Over-expression of a 
polyglutamine expanded Htt that is resistant to caspase-6 cleavage did not show any 
form of neurodegeneration, but this was not the case for a caspase-3 resistant form of 
Htt.  It has been hypothesized that these cleavage products would first form soluble 
oligomers and later aggregate in protein inclusions together with other proteins 
(Kawaguchi, Kovacs et al. 2003).  However, it is not clear how these inclusions cause 
toxicity.  It is likely that these oligomers like other misfolded proteins are directed to 
the ubiquitin-proteasome system for degradation.  However, the proteasome has been 
shown to be dysfunctional in many models of polyglutamine expansion diseases 
(Bence, Sampat et al. 2001; de Pril, Fischer et al. 2004; Ross and Poirier 2004; 
Pandey, Nie et al. 2007).  The mechanism of proteasome inhibition is not known, but 
the reason is likely to be related to either aberrant oligomers or misfolded 
polyglutamine proteins.   
The association of protein inclusion formation and neurodegeneration raises 
the question whether inclusions are toxic.  Several lines of evidence in recent years 
suggested that inclusions are by products of protein stress and are not exclusively 
toxic to the cell.  In a population of cells expressing polyglutamine-expanded Htt, 
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cells with inclusions were shown to survive significantly longer than cells without 
inclusions (Arrasate, Mitra et al. 2004).  Cells without inclusions have more soluble 
oligomers of Htt with polyglutamine expansion, which positively correlated with 
shortened life span.  Moreover, in a mouse model of SBMA soluble oligomers were 
detected several weeks before the onset of symptoms, and symptoms would start 
before inclusion formation was observed (Li, Chevalier-Larsen et al. 2007).  
Significantly, soluble oligomers cleared upon castration.  These studies and others 
(Taylor, Tanaka et al. 2003; Slow, Graham et al. 2005) suggest that soluble oligomers 
are the toxic species, that toxicity may be achieved by inhibiting the proteasom , and 
that protein inclusion formation is an end point that stabilizes these oligomers.  This 
speculation is challenged by the transcription factor deactivation hypothesis discussed 
above.  Since aberrant oligomers and inclusions can sequester transcription factors, 
inclusions formed inside the nucleus could modify gene expression.  It is likely that 
pathogenesis of polyglutamine expansion diseases is a result of combination of 
several factors (Shao and Diamond 2007).    
Cell response to protein stress: the ubiquitin-proteasome system and 
autophagy 
The ubiquitin-proteasome system 
The proteasome system and autophagy are the two major catabolic systems in the 
cell.  The proteasome system is the best characterized catabolic system (Etlinger and 
Goldberg 1977), and it is essential for the degradation of short lived proteins that 
function in critical signaling pathways.  Among the pathways that the proteasom  
regulates are cell cycle progression, differentiation and development, modulatin of 
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cell surface receptors, DNA repair, and the immune system (Ciechanover, Orian et al. 
2000).  Degradation of proteins by the proteasome system involves poly-
ubiquitination of a target protein by the collaborative action of three enzymes 
followed by degradation by the 26S proteasome.  Each ubiquitin moiety is activated 
by a ubiquitin activating enzyme (E1) by converting C-terminal Gly of ubiquitin to a 
high energy thiol ester by a Cys residue.  Then a ubiquitin conjugating enzyme (E2) 
transfers this activated ubiquitin to the target protein that has been bound to a 
ubiquitin-protein ligase (E3).  The target protein is poly-ubiquitinylated by succe sive 
repetitions of this reaction (Glickman and Ciechanover 2002).   This central 
mechanism in the cytosol holds true for all the proteins that are targeted to the 
proteasome.  Endoplasmic reticulum (ER) and nuclear proteins that are targeted for 
degradation are thought to be first transported out of their organelles.   
During ER-associated degradation (ERAD), proteins or subunits in the ER that 
are misfolded or unassembled are targeted to the proteasome.  These proteins are 
transported into the cytoplasm by a channel that contains Sec61 as a structural 
element, and then ubiquitinylated and degraded in the cytoplasm (Scott and 
Schekman 2008).  Failure of ERAD leads to protein stress in the ER that can lead to 
species of protein oligomers that are often associated with inhibition of the 
proteasome and formation of protein inclusions in the cytoplasm (Bence, Sampat et 
al. 2001).  The collective defensive response that the cell launches in an ER protein 
stress is referred to as unfolded protein response (UPR).  It refers to a variety of 
adaptations that increase molecular chaperone expression, decrease overall translation 
rate and increase degradation of misfolded proteins (Schroder and Kaufman 2005).  
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In addition, prolonged UPR may activate apoptotic pathways (Hetz, Bernasconi et al. 
2006).   Several disorders have been associated with altered UPR, including cystic 
fibrosis (Johnston, Ward et al. 1998).   
Autophagy   
 Three forms of autophagy have been described, including macro-autophagy, 
micro-autophagy and chaperone-mediated autophagy (Reggiori and Klionsky 2002). 
Macro-autophagy (hereafter referred to as autophagy), literally “sef-eating”, is 
classically regarded as a bulk degradation system of long-lived proteins and 
organelles, and is the best studied form of this process.  Autophagy is used to deliver 
cargo, including proteins and organelles, to the lysosome for degradation (Klionsky 
and Emr 2000).  Autophagy is activated in response to starvation conditions, and 
provides metabolic substrates that promote cell survival (Takeshige, Baba et al. 1992; 
Thumm, Egner et al. 1994).  Recent evidence suggests that autophagy is not just a 
bulk, non-selective degradation system, but has more specific functions that entail 
intricate regulation.  These include elimination of bacteria, antigen presentation and 
programmed cell death (Deretic 2005; Mizushima 2005).  Autophagy commences 
with formation of a double membrane isolation vesicle in the nucleation site, which is 
called the pre-autophagosomal structure (PAS).  The isolation membrane 
encapsulates cytoplasmic components to form the “autophagosome” which fuses with 
the lysosome where substrates are degraded by hydrolases.  The origins of the PAS 
and isolation membrane are not clear.   However, recent evidence suggests that ER
membrane can serve as the source for the isolation membrane (Axe, Walker et al. 
2008), but this remains controversial and it is possible that other membranes may be 
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used to initiate autophagy.  Completion of the isolation membrane requires the 
activity of two conjugation systems (Ohsumi 2001).  The Atg12 conjugation system 
results in the formation of the Atg12, Atg5 and Atg16 complex, while the Atg8 
system results in conjugation of phosphatidylethanolamine (PE) to Atg8 (LC3 in 
mammals), which serves as a structural element of isolation membranes and 
autophagosomes (Kabeya, Mizushima et al. 2000; Xie, Nair et al. 2008).  This has led 
to utilization of fluorescent protein tagged Atg8/LC3 as a marker of autophagosomes.  
Moreover, there is  evidence suggesting that the Atg12-Atg5 complex promotes 
lipidation of Atg8 (Hanada, Noda et al. 2007).  How the autophagosome meets with 
the lysosome is not clear, but once it docks and fuses to a lysosome, the inner 
autophagosome membrane with its contents enter the lysosome.  In addition, 
autophagic and endocytic pathways can converge to form “amphisomes”, which later 
are degraded by the lysosome (Berg, Fengsrud et al. 1998).  This suggests an intimate 
interaction between vesicular trafficking pathways in the cell, and the regulation of 
both autophagy and endosome maturation by the Vps34, Vps15, and Atg6 (Beclin1 in 
mammals) complex supports this conclusion (Juhasz, Hill et al. 2008).   
Autophagy in neurons and neurodegeneration 
Studying autophagy in the nervous system has been challenging because of the 
difficulty to observe autophagic structures under physiological conditions.  An 
investigation in the nervous system of mice carrying an autophagosome reporter 
transgene did not lead to any observation of autophagosomes under either 
physiological or under starvation conditions (Mizushima, Yamamoto et al. 2004).  
Indeed, for a long time autophagic structures had only been seen in the nervous 
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system upon severe stress, and during re-growth and regeneration upon injury 
(Rubinsztein, DiFiglia et al. 2005).  Several studies have reported autophagic 
structures in the neurons of neurodegenerative disease models (Kegel, Kim et al. 
2000; Nixon, Wegiel et al. 2005; Boland, Kumar et al. 2008).  Most of these studies 
assumed that autophagy was involved in the turnover of organelles and cytoplasm 
during repair.   
Landmark studies of atg5 and atg7 conditional knockout mice in the nervous 
system significantly advanced our understanding of the importance of autophagy in 
neurons (Hara, Nakamura et al. 2006; Komatsu, Waguri et al. 2006).  These knockout 
mice had reduced longevity, severe motor deficiency at birth, and histologcal 
analyses of their nervous system revealed significant neuronal damage associated 
with DNA fragmentation.  Histological and ultrastructural analyses reveal d that mice 
lacking atg5 and atg7 had ubiquitinylated fibrillar inclusions in their nervous system 
that is reminiscent of neurodegenerative disease.  Importantly, tg7 mice had a 
normally functioning proteasome system.  These results showed that autophagy was 
essential for nervous system function, and that basal autophagy in neurons is critical 
for the health and homeostasis of the brain.  The inability to observe autophagic 
structures in the nervous system under physiological conditions has been attributed to 
a very efficient rate of autophagy such that autophagic structures could not be
detected (Cuervo 2006; Boland, Kumar et al. 2008).   
The observation of autophagic vacuoles in neurodegenerative models, and the 
presence of protein inclusions in autophagy mutant mice, led to extensive 
investigation of the role of autophagy in neurodegenerative diseases.  Autophagy 
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could either degrade cells or be activated to cope with the protein stress that leads to 
inclusion formation during neurodegeneration (Levine and Kroemer 2008).  In 
support of the latter possibility, activation of autophagy reduced the toxicity of Htt
polyglutamine expansion in fly eyes and motor activity of mice respectively 
(Ravikumar, Vacher et al. 2004).  In this study, we investigated the role of autophagy 
in a fly model of SBMA (Chapter 2).     
Autophagy and the proteasome system 
The observation of ubiquitin-positive protein inclusions in atg gene knockout 
mice suggests that the function of the proteasome system and autophagy are related. 
This may imply that proteasome substrates can be degraded by autophagy.  In a cell 
line model of Parkinson’s disease the mutant form of α-synuclein, which causes the 
disease, was found to be degraded by both the proteasome system and autophagy 
(Webb, Ravikumar et al. 2003; Cuervo, Stefanis et al. 2004).  Therefore, the 
proteasome system and autophagy are capable of degrading the same substrate.    
While studies on the relationship of the proteasome system and autophagy are in 
their infancy, several candidate proteins emerged that may be involved in this 
relationship.  HDAC6 is a cytoplasmic histone deacetylase that belongs to a different 
class than nuclear histone deacetylases (Grozinger, Hassig et al. 1999).  It is primarily 
found in the cytoplasm associated with microtubules.  It has a ubiquitinylated protin 
binding domain, and it was shown to bind to dyneins (Hubbert, Guardiola et al. 
2002).  It was suggested that HDAC6 is directly involved in the formation of 
specialized protein inclusions that are surrounded by membranes called “aggresomes” 
(Kawaguchi, Kovacs et al. 2003; Boyault, Gilquin et al. 2006).   
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Another protein that may link the ubiquitin-proteasome system and autophagy is 
p62.  It has an ubiquitinylated protein binding domain, a PB1 domain that facilitates 
polymerization, and an LC3/Atg8 binding domain (Ichimura, Kumanomidou et al. 
2008).  The involvement of p62 in inclusion formation was confirmed in hepatocytes 
derived from autophagy deficient mice.  While autophagy mutants developed 
ubiquitin positive inclusions, autophagy and p62 double mutants failed to form 
inclusions (Komatsu, Waguri et al. 2007).  p62 and ubiquitin-positive protein 
inclusions were formed in a cell line model of Huntington’s disease that resul ed in 
proteasome inhibition, and the p62 in inclusions were physically bound to and co-
localized with Atg8, suggesting that inclusions were recognized and degraded by 
autophagic machinery (Bjorkoy, Lamark et al. 2005).  Moreover, a recent study 
characterized the crystal structure of Atg8 and p62 binding. In this study, point 
mutations in the Atg8 binding domain resulted in ubiquitin positive inclusion 
formation.  These results suggest that p62 provides a direct link between 
ubiquitinylated proteins and autophagy (Ichimura, Kumanomidou et al. 2008).    
Finally, the autophagy linked FYVE protein (Alfy) was suggested to be involved 
in autophagic clearance of ubiquitinylated proteins.  Alfy has a FYVE domain th t 
binds to phosphatidylinositol-3-phosphate, which is necessary for induction of 
autophagy (Simonsen, Wurmser et al. 2001).  In starved HeLa cells, Alfy co-localizes 
with Atg8 showing its association with autophagic machinery.  In addition, during 
proteasome inhibition of HeLa cells Alfy localized to ubiquitin positive protein 
inclusions (Simonsen, Birkeland et al. 2004).  In Drosophila, mutations in the Alfy’s 
homolog blue cheese cause progressive neurodegeneration with amyloid like protein 
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inclusion pathology (Finley, Edeen et al. 2003).  These findings imply that Alfy may 
function in catabolic degradation of proteins.   
Dyneins and neurodegeneration 
Dynein: a unique molecular motor protein 
Molecular motors are specialized protein complexes that provide directed 
movement in cells.  They are composed of three main families: actin based myosins, 
microtubule based kinesins and dyneins (Schliwa and Woehlke 2003).  Myosins and 
kinesins have been extensively classified into at least 17 and 14 classes respectively, 
since they are composed of components with high sequence variability.  By contrast, 
dyneins have been classified into only 2 classes (axonemal and cytoplasmic) due to 
their high sequence conservation across species and cellular compartments (Hook and 
Vallee 2006).  Myosins are classically localized to cell cortex and are involved in 
maintaining cell shape.  However, a number of so-called unconventional myosins 
have been found to be involved in many key cellular events including organelle 
transport and endocytosis (Wu, Jung et al. 2000).  Kinesins are involved in movement 
of cargo towards plus end of microtubules (towards the cortex), while dyneins 
towards minus end (towards the nucleus).  Even though they both function on 
microtubules, kinesins and dyneins are structurally and functionally distinct.  
Nevertheless, they are interdependent, since inhibiting either dyneins or kinesins 
disrupts movement on microtubules in both directions (Martin, Iyadurai et al. 1999).  
This interdependence could be due to the necessity of dyneins to be carried by 
kinesins to the distal ends of the cell whence they can start their retrograde movement 
(Ligon, Tokito et al. 2004).        
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Dyneins are members of the ATPase superfamily with a large (~3000 amino cid) 
modular motor region that is composed of 6 ATPase modules, which collectively 
make up the dynein heavy chain (DHC, ~500 kDa) (Shpetner, Paschal et al. 1988).  
The dynein heavy chain binds to a variety of smaller subunits: intermediate chains 
(ICs, ~60-140 kDa), light intermediate chains (LICs, 30-60 kDa) and light chains 
(LCs, 8-30 kDa) (Vallee, Williams et al. 2004).  The classic view of a dynein motor is 
that each dynein complex is composed of two DHCs, two ICs, two LICs and a 
variable number of LCs (Vallee, Wall et al. 1988).  However, this view has been 
challenged in more recent years (Wickstead and Gull 2007).   Moreover, ICs bind to 
an important binding partner, p150Glued that is a structural element of dynactin, which 
increases efficiency of dynein movement (Karki and Holzbaur 1995; Vaughan and 
Vallee 1995).   
LCs, which bind to the dynein complex through the ICs, are primarily responsible 
for cargo recognition.  Three classes of LCs have been identified that are specific for 
the cytoplasmic dynein: Tctex, LC8 and LC7.  Tctex-1 has been found to interact 
with rhodopsin, Trk receptor and others (Tai, Chuang et al. 1999; Yano, Lee et al. 
2001).  LC7 has been found to interact with TGFβ receptor (Tang, Staub et al. 2002).   
LC8 is the most conserved of the light chains and has been found to interact with 
numerous cargos (Jaffrey and Snyder 1996; Puthalakath, Huang et al. 1999; Lo, Kan 
et al. 2005).  Interestingly, LC8 was shown to function in the regulation of binding 
partners without the involvement of motor activity or association with other dyneins 
(Puthalakath, Huang et al. 1999).  Moreover, while higher plant genomes contain LC8 
homologous sequences, they do not contain sequences of any of the other dynein 
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components (Lawrence, Morris et al. 2001; Wickstead and Gull 2007).  This implies 
that LC8 could have functions that are different than motor activity in plants, even 
though, it cannot be ruled out that these findings could be due to unusual dynein 
sequence variability in plants.   
Dyneins in the mechanism of autophagic movement 
The need for autophagosomes to dock and fuse with lysosomes implies that there 
is a mechanism to move either of these organelles to meet with each other in the 
cytoplasm.  There are several lines of evidence indicating that once form d, 
autophagosomes move in a dynein-dependent fashion towards the centrosome, where 
lysosomes are thought to be concentrated. First, microtubule disruption in hepatocytes 
significantly reduces autophagosome-lysosome fusion events (Kochl, Hu et al. 2006). 
Second, microtubule destabilizing agents such as nocodazole inhibit the formation 
and regular movement of autophagosomes in cell lines (Fass, Shvets et al. 2006; 
Kimura, Noda et al. 2008).  Third, inhibition of dynein components, the dynein 
intermediate chain or the p150Glued disrupts regular movement of autophagosomes 
(Kimura, Noda et al. 2008).  Since microtubule disruption inhibits autophagosome 
formation, dyneins may also be involved in bringing cytoplasmic components 
destined for autophagic degradation to the pre-autophagosomal structure, although 
there is no direct evidence for this possibility. 
Dynein mediated transport in neurons 
 Endocytic vesicles that are transported by dyneins from axon ends to the cell 
body in neurons are also called “signaling endosomes” due to their cargo that 
contains signaling molecules.  The most studied example is transport of the family of 
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neuronal growth factors (NGFs) collectively known as neurotrophins.  The NGFs that 
are released from the axon bind to tyrosine kinases (Trks) or to p75 receptors and this 
is followed by the formation of endocytic vesicles (Grimes, Beattie et al. 1997; 
Bronfman, Tcherpakov et al. 2003).  Following endocytosis, NGFs influence axon 
and dendrite growth, and neuronal differentiation (Zweifel, Kuruvilla et al. 2005).  
For the signal to take any effect, the endocytic vesicle has to be transported through 
the axon to the cell body (Ye, Kuruvilla et al. 2003).  Retrograde transport of NGFs is 
essential for neuronal survival since removal of NGFs from axon ends but not from 
the cell body leads to cell death (Campenot 1977).  This retrograde transport is dynein 
dependent, since disruption of dynein activity impairs the transport of NGFs 
(Heerssen, Pazyra et al. 2004).  In addition to signaling endosomes, dyneins also 
carry proteins with nuclear localization signal (NLS), such as transcription factors, to 
the nucleus.  Following neuronal injury, retrograde transport of NGFs decrease 
significantly, while transport of NLS containing proteins increases (Raivich, Hellweg 
et al. 1991).  The interaction of dyneins and NLS containing proteins are maintained 
by “importins”, which also mediate nuclear import of these signals through the 
nuclear core complex (Hanz and Fainzilber 2006).  Downregulation of this signaling 
by ectopic expression of dominant negative NLS proteins impairs regeneration of 
neurons (Hanz, Perlson et al. 2003).  Intriguingly, in injured neurons the dynein-
importin complex can transport some signaling proteins without an NLS through 




Dynein mutations that result in neurodegeneration  
The importance of retrograde transport and therefore of dyneins for neuronal 
survival led to investigations of the outcomes of dynein mutations in the nervous 
system.  Since peripheral neurons have long axons spanning throughout the body, the 
effects of dynein loss is likely to be considerable in these neurons.   Retrograde 
transport was defective in a mouse model of the motor neuron disease ALS which 
contained a dominant negative form of SOD1 (sod1G93A) (Murakami, Nagano et al. 
2001).  However, only a minority of ALS cases is due to mutations in sod1 
(Cleveland and Rothstein 2001).  Other mutations that caused ALS in mice were 
identified in the dynein heavy chain (Hafezparast, Klocke et al. 2003): heterozygous 
loa/+ and cra/+ mice had significant muscle and motor neuron loss with a pathology 
of protein inclusion formation that are positive for neurofilaments and SOD1.  
Another mouse mutation in the dynein heavy chain called sprawling (swl) had a 
phenotype similar to loa (Chen, Levedakou et al. 2007).  Interestingly, ALS 
phenotype of the sod1G93A mice is partially rescued in the double mutant mice 
sod1G93A/loa (Kieran, Hafezparast et al. 2005) and in sod1G93A/cra but not in 
sod1G93A/swl (Teuchert, Fischer et al. 2006).  This partial rescue could be due to 
inability to transport the dominant negative SOD1G93A within the motor neurons of 
loa and cra heterozygotes.  This hypothesis is supported by the detection of SOD1 in 
protein inclusions that appear in the motor neurons of the loa/+ and cra/+ mice.  The 
inability of swl to ameliorate sod1G93A phenotype could be due to swl being a weaker 
allele however, this subject is under debate (Strom, Gal et al. 2008).  The 
aforementioned mutants are all in dynein heavy chain.  This raises the question of 
whether mutations in other subunits of dynein could cause neuron disease.  A 
23 
 
mutation was found in the structural element of dynactin, p150Glued, in a family with 
progressive motor neuron disease (Puls, Jonnakuty et al. 2003).  Later a mouse line 
carrying the mutant form of the p150Glued was generated (Lai, Lin et al. 2007).  These 
mice had slowly progressing motor neuron disease with the pathology of motor 
neuron loss and decrease in locomotor functions.  Interestingly, another mouse line of 
the same p150Glued mutation was described to result in a weak form of the 
polyglutamine expansion disease spinobulbar muscular atrophy (SBMA) with a 
pathology of distal motor neuron degeneration (Chevalier-Larsen, Wallace et al. 
2008).  In this mouse line, however, retrograde transport was normal, perhaps due to 
weaker expression of the mutant form of p150Glued.  Furthermore, transcription of 
dynactin and the rate of retrograde transport were found to be significantly reduced in 
a mouse model of SBMA expressing mutant human androgen receptor (Katsuno, 
Adachi et al. 2006).  This mouse model displays protein inclusions and loss of motor 
neurons.  Upon castration these symptoms disappear together with the restoration of 
dynactin transcript and of the rate of retrograde transport.   
In addition to mutations in dynein, a mutation in a kinesin was found to cause 
motor neuron disease in humans and a mouse model (Zhao, Takita et al. 2001).  
Taken together these studies demonstrated the importance of microtubule based 
transport and of dyneins in neuronal function.           
Cell death 
The death of neurons is a common pathogenic observation in neurodegenerative 
diseases.  Although dysfunctional neurons that have not yet died may contribute to 
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neurodegenerative symptoms, studies of neuronal death will help to complete our 
understanding of the disease process.  
Three morphological forms of cell death have been observed during development, 
including apoptotic, autophagic and non-lysosomal (necrotic) cell death (Schweichel 
and Merker 1973; Clarke 1990).  Apoptotic cell death is the most studied and is 
characterized by DNA fragmentation, cell condensation, and membrane blebbing 
(Kerr, Wyllie et al. 1972).  Apoptotic machinery is triggered by cytochrome c releas  
from the mitochondria followed by the assembly of the apoptosome that includes the 
apoptotic protease activating factor (Apaf-1) and caspase 9 (Liu, Kim et al. 1996; 
Zou, Henzel et al. 1997).  Even though this process is generally well conserved, it’s 
been suggested that the apoptosome assembly does not require cytochrome c releas 
in Drosophila (Dorstyn, Read et al. 2002).   Apoptosome assembly is followed by 
downstream activation of effector caspases such as caspase-3, which degrades many 
cell substrates thereby triggering cell death (Timmer and Salvesen 2007).  Last stage 
of apoptosis is removal by a phagocyte following the recognition of the “eat me” 
signal on the plasma membrane of the apoptotic cell (Savill and Fadok 2000).  The 
best characterized of these signals is the phospholipid phosphatidylserine (Fadok, 
Voelker et al. 1992).  The contribution of apoptosis to neurodegenerative diseases is 
not clear.  Several studies reported activation of caspases in neurodegenerative 
disease models, which may imply cell death by apoptosis (Wootz, Hansson et al. 
2004; Yamada, Iwatsubo et al. 2004).  In addition, loss of function of the Apaf-1 
homolog in Drosophila reduced neurodegeneration in a model of HD, supporting the 
role of apoptosis in neurodegeneration.  By contrast, neurodegenerative symptoms 
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were dependent on caspase-6 mediated cleavage of Htt in another model of HD 
suggesting that caspase activation may serve to initiate the disease process rather than 
killing the cell (Graham, Deng et al. 2006).        
Autophagic cell death is characterized by the presence of numerous 
autophagosomes and autolysosomes containing cytoplasmic components in dying cell 
(Baehrecke 2005).  Unlike apoptosis, cells dying with an autophagic morphology are 
not cleared by phagocytosis, and instead they degrade using their own lysosomal 
enzymes.  Caspase activation has also been implicated in autophagic cell death. 
Drosophila larval salivary glands die as part of the developmental program in a 
caspase and autophagy dependent manner, without phagocytosis (Martin and 
Baehrecke 2004; Berry and Baehrecke 2007).  In addition, it has been reported that 
brain damage due to constriction of blood supply (cerebral ischemia) involves cell 
death by caspase activation with autophagic morphology (Rami and Kogel 2008).  By 
contrast, autophagic cell death was observed in cell lines that were defective in 
activating caspases (Shimizu, Kanaseki et al. 2004).  Moreover, it is well established 
that ectopic activation of autophagy is sufficient to kill cells (Scott, Juhasz et al. 
2007).  Although autophagy has been associated with many examples of dying cells 
in diverse taxa, the precise role of autophagy during cell death requires further
investigation.   
Necrotic cell death is due to short, detrimental insults that result in swelling of 
organelles and loss of cellular integrity (Schweichel and Merker 1973).  Necrotic cell 
death might be an alternative to other forms of cell death and it does not utilize the 




Disruption of the fine balance between anabolism and catabolism is likely to have 
important consequences to the cell.  Dysfunctional catabolism and protein stress has 
been linked to toxicity in neurodegenerative diseases.  Here, I first investigat  the 
relationship between the proteasome system and autophagy in a Drosophila model of 
spinobulbar muscular atrophy (SBMA).  Next, I investigate the consequences of a 
mutation in dynein light chain that causes defects in protein clearance, larval s livary 














Table 1 : Common Neurodegenerative Diseases 
Name Cause Symptoms Pathology 
                                                     Non-Polyglutamine Expansion Diseases 
Alzheimer's disease 
(adult onset [7th to 9th 
decades], progressive) 
Autosomal dominant   (3 
to 5 % of cases), 
sporadic.  Mutations in 









Sclerosis (adult onset 
[5th to 6th decades], 
progressive) 
Mutation of superoxide 
dismutase 1 (SOD1, less 
than 20% of cases), 
sporadic. 
Muscle weakness, lack 




Degeneration of motor 
neurons, protein 
inclusions and axonal 
swelling. Death within 
3 to 5 years of 
diagnosis. 
Parkinson’s disease 









Loss of dopaminergic 
neurons in substantia 
nigra, protein 
inclusions called Lewy 
bodies. 
Polyglutamine Expansion Diseases 
Dentatorubral-
pallidoluysian 
atrophy (DRPLA)                                                                                                                              
(adult or juvenile 
onset, progressive) 
Autosomal dominant, 




ataxia, lack of 
coordination, 
dementia. 
Central nervous system 
atrophy, protein 
inclusions.











Neuronal loss of 
striatum, frontal and 
temporal cortex. 





Seen in adult males, 
progressive. 
Autosomal dominant, 
CAG expansion of 
androgen receptor (AR). 
Requires testosterone. 
Tremor of the hands, 
muscular atrophy, 
impairment of motor 
functions. 




ataxias (Types 1, 2, 3, 
6, 7, 17, adult onset, 
progressive) 
Autosomal dominant, 
CAG expansion of ataxin 
(ATXN). 
Lack of coordination 
of movements. 
Neuronal loss, protein 
inclusions, blindness, 
early fatality. 




The proteasome and autophagy are cytoprotective in a
Drosophila model of Spinal Bulbar Muscular Atrophy 
This study is part of a published collaborative work referenced below: 
Pandey, U.  B., Z.  Nie, Y.  Batlevi, Y. et al.  (2007).  "HDAC6 rescues neurodegeneration and 
provides an essential link between autophagy and the UPS." Nature 447(7146): 859-63. 
Abstract 
The neurons of most neurodegenerative disorder patients contain protein 
inclusions, which suggest that insufficient protein degradation might be a factor in 
disease.   The ubiquitin proteasome system and the autophagy are the major 
contributors of catabolic degradation.  We observed that when the proteasome is 
inhibited by expression of a dominant negative subunit, autophagy is induced.  We 
generated a Drosophila model of spinal bulbar muscular atrophy (SBMA) that 
recapitulates the characteristics of this disease in the eye, including liga d- and 
length-dependent degeneration.  We show that the proteasome system is impaired in 
this SBMA model, and autophagy is induced.   Moreover, further induction of 
autophagy by ectopic expression of PTEN is cytoprotective, and impairment of 
autophagy enhances degenerative phenotypes.  We suggest that proteasome inhibition 
contributes to neurodegenerative symptoms, and that autophagy acts to compensate 






Protein inclusion formation is a pathological hallmark of neurodegenerative 
diseases, but the significance of inclusion formation is not known.  Protein inclusions 
frequently contain the fragments of the mutant protein, such as either Htt or androgen 
receptor in the contexts of either Huntington’s disease or SBMA, in addition to other 
proteins, including transcription factors, heat shock proteins and ubiquitin 
(McCampbell, Taylor et al. 2000; de Pril, Fischer et al. 2004).  Polyglutamine 
expansion diseases are caused by gain of function mutations, and are transmitted in a 
dominant fashion (Gurney, Pu et al. 1994; Orr and Zoghbi 2007).  Importantly, 
complete deletion of the genes responsible for some of these diseases does not cau e 
neurodegeneration (Brown, Lubahn et al. 1988; Brinkmann 2001).  How the 
expansion of polyglutamine leads to toxicity is not fully understood.  It has been 
reported that proteins with large numbers of glutamines tend to misfold (Welch and 
Diamond 2001).   This observation led to the hypothesis that neurodegenerative 
diseases could be protein confirmation diseases in which the capacity of misfolded 
protein load is increased beyond the ability of the cell to degrade these proteins 
(Nedelsky, Todd et al. 2008).  There is increasing evidence that inclusions are not 
toxic but the smaller soluble oligomers are, and inclusions are formed as an end result 
(Taylor, Tanaka et al. 2003; Arrasate, Mitra et al. 2004; Li, Chevalier-Larsen et al. 
2007).    
The hypothesis of toxic misfolded protein load led to investigations of the 
degradation pathways in the context of neurodegenerative diseases.  If a newly 
synthesized protein cannot be refolded by molecular chaperones it is ubiquitinylated 
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and targeted to the 26-S ubiquitin proteasome for degradation (Ciechanover, Orian et 
al. 2000).  The presence of ubiquitin in protein inclusions of neurodegenerative 
disease patients may suggest proteasome’s involvement in the effort to degrade 
aberrant proteins before they accumulate in inclusions.  The proteasome was found to 
be inhibited in neurodegenerative diseases (Bence, Sampat et al. 2001; Ross and 
Pickart 2004).  In addition, there is evidence that proteasome inhibition occurs before 
protein inclusion formation (Bennett, Bence et al. 2005).  Therefore, it has been 
suggested that protein inclusions form as a result of protein stress and inability of the 
proteasome to degrade misfolded proteins (Johnston, Ward et al. 1998).  Protein 
inclusions could serve as an intermediary step to degrade aberrant proteins by other
catabolic processes in the cell (Taylor, Tanaka et al. 2003).   
The other major degradation mechanism in the cell is autophagy, which utilizes 
lysosomes to degrade cellular components that are sequestered in double-membrane 
vesicles.  Autophagy is used for the turnover of long-lived proteins and organelles 
(Klionsky and Emr 2000; Mizushima 2005).  Autophagic structures were found in 
multiple neurodegenerative disease models (Kegel, Kim et al. 2000; Nixon, Wegiel et 
al. 2005; Boland, Kumar et al. 2008).  Pharmacological induction of autophagy in cell 
lines of neurodegenerative disease models can degrade aberrant proteins, including 
polyglutamine expanded Huntingtin and proteins with polyalanine expansion 
(Ravikumar, Duden et al. 2002; Ravikumar, Vacher et al. 2004). 
The polyglutamine expansion diseases are caused by the expansion of the 
naturally occurring glutamine repeat regions in some proteins (Zoghbi and Orr 2000).  
These diseases include the Huntington’s disease, spinal bulbar muscular atrophy 
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(SBMA), spinocerebellar ataxias (SCAs) and the dentatorubral pallidoluysian atrophy 
(DRPLA) (Table 1).  SBMA was the first disease to be associated with glutamine 
repeat expansion.  It is seen in people with polyglutamine expanded androgen 
receptor (AR) and it is transmitted in a dominant fashion (Brown, Goss et al. 1989; 
La Spada, Wilson et al. 1991).  High concentrations of AR’s ligand testosterone is 
required for disease to occur, hence it is a male-specific disease.  In mouse odels of 
SBMA, female littermates do not show the disease and castration of males stops the 
disease progression (Li, Chevalier-Larsen et al. 2007).  As in other polyglutamine 
expansion diseases, symptoms start in adults and progress over time.  Most people 
without the disease have approximately 20 glutamine repeats in their AR, and 40 
repeats of glutamine is the threshold for symptoms to occur.  Patients who have AR 
with higher numbers of polyglutamine repeats start seeing symptoms earlier in lif  
and disease symptoms progress more rapidly (Doyu, Sobue et al. 1992).  Major 
symptoms are muscular cramps, atrophy, tremor of the hands and androgen 
insensitivity.   
In this study we describe an i  vivo model of SBMA that recapitulates the disease 
in the fly eye.  We show that expression of the expanded AR in the eye causes 
degeneration in a polyglutamine length-dependent fashion.  The proteasome is 
inhibited in this model, and autophagy is induced.  Genetic activation of autophagy 
ameliorates this degeneration.  Moreover, proteasome impairment alone causes eye 
degeneration and autophagy induction, implying that the disease symptoms are due to 
misfolded protein stress caused by proteasome inhibition.   
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Materials and Methods 
Fly Strains:  
Drosophila stocks were maintained on standard fly food either at 25OC or at room 
temperature.  Dihydrotestosterone (DHT) was dissolved in absolute ethanol and 
added to liquid fly food to a final concentration of 1 mM.  The GMR-GAL4 strain 
was obtained from Bloomington Stock Center (Indiana University, Bloomington, IN).  
uas-DTS7 strain was provided by Dr. Eric Fortier (Syracuse University, Syracuse, 
NY).  uas-CL1-GFP strain and the human AR with 12, 20, 45, 52, 121 CAG repeats 
containing strains were provided by Dr. J. Paul Taylor (St. Jude Children’s Medical 
Center, Memphis, TN).  uas-Atg6 RNAi and uas-Atg12 RNAi (Pandey, Nie et al. 
2007) strains were used to down-regulate autophagy.  uas-PTEN (Huang, Potter et al. 
1999) strain was used to activate autophagy.  
Electron Microscopy: 
Scanning electron microscopy (SEM) samples were collected and fixed in 2.5% 
gluteraldehyde (EMS, Fort Washington, PA) in PBS, and post-fixed for 15-30 
minutes in 1.5% osmium tetroxide (Stevens Metallurgical, NY) in PBS.  Samples 
were then dehydrated in ethanol, immersed in hexamethyldisilazane (Polysciences 
Inc.  Warrington, PA) and dried in a dessicator for three days.  Specimens were then 
coated with gold:palladium using a Denton DV-503 vacuum evaporator, and analyzed 
using an AMRAY 1820D scanning electron microscope.   
For TEM evaluation, fly heads were fixed with 2.5% gluteraldehyde/2% 
formaldehyde with 0.1 M sodium cacodylate and stored at 4°C until embedding.  
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Heads were post-fixed with 2% osmium tetroxide followed by an increasing gradient 
dehydration step using ethanol and propylene oxide.  Heads were then embedded in 
LX-112 medium (Ladd) and sections were cut ultrathin (90 nm), placed on uncoated 
copper grids, and stained with 0.2% lead citrate and 1% uranyl acetate.  Images were 
examined with a JEOL-1010 electron microscope (JEOL) at 80 kV.   
Immunohistochemistry: 
To image imaginal eye discs, wandering third instar larvae were dissected in 
standard Drosophila saline containing 128mM NaCl, 4mM MgCl2, 2mM KCl, 
0.4mM CaCl2, 70mM sucrose and 5mM HEPES29.  After dissection, whole larval 
brains containing attached eye imaginal discs were fixed in 4% paraformaldehyde for 
30 minutes on ice and washed with standard saline three times.  Eye imaginal discs 
were mounted in Glycergel Mounting Medium (DAKO) and viewed on a Bio-Rad 
MRC 1024 ES confocal laser scanning module on a Nikon Eclipse E600 and 
examined by using LaserSharp software. 
Results: 
Drosophila model of spinal bulbar muscular atrophy 
In order to develop a Drosophila model of SBMA, transgenic flies containing full 
length human AR with 12, 20, 45, 52, and 121 glutamine stretches were expressed in 
the eye by GMR-GAL4 using the UAS/GAL4 system (Brand and Perrimon 1993).  
Expression of AR with different glutamine stretches did not cause a considerable 
defect in the eye morphology (Figure 2-1, top row).  By contrast, expression of AR 
with different glutamine stretches in flies reared on AR’s natural ligand 
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dihydrotestosterone (DHT) containing food resulted in considerable degeneratio  of 
the eye in a polyglutamine (polyQ) stretch length dependent manner (Figure 2-1, 
bottom row).  This degeneration is most severe in the posterior margin and entails a 
disorganization of the ommatidial array, fusion of ommatidia, and disorganization of 
ommatidial bristles.  The polyQ stretch length dependency mirrors the disease n 
humans, since the disease symptoms are more severe in patients that have AR with 
higher numbers of glutamine repeats.   
To investigate the relationship between polyglutamine length and age of disease 
onset, we took advantage of the ligand-dependency of this model.   Flies expressing 
AR containing 12, 52 and 121 glutamine repeats were reared on standard fly food 
until eclosion, and then adults were transferred to DHT-containing food.  Theseadults 
were regularly transferred to fresh food that contained DHT, and they were obseved 
daily for changes in the eye morphology.  Flies expressing AR with 121 glutamine 
repeats exhibited a polyQ- length dependent degeneration earlier than flies expr sing 
AR with 52 glutamine repeats (Figure 2-2, bottom and middle rows).  The average 
number of days to the onset of the degenerative phenotype in flies expressing AR 
with 52 glutamine repeats was 23.7 days.  This average was 18.9 days in flies 
expressing AR with 121 glutamine repeats.  Flies expressing AR with 12 glutamine 
repeats did not show a significant degeneration by day 60 after when the experiment 
was stopped (Figure 2-2, top row).  Earlier onset of degeneration with increasing 
polyQ length mirrors the disease in humans, since the disease symptoms start earlier 
in life in patients that have AR with higher numbers of glutamine repeats.  Taken 
together, expression of human AR with different polyQ stretches in the Drosophila 
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eye provides a model with the characteristics of the age of onset and severity of the 
SBMA in human patients.          
 









Figure 2-1: Eye degeneration is enhanced by increased polyglutamine stretch in 
the AR. 
SEM pictures of the Drosophila eye of 1 day old flies showing the SBMA model 
generated by expressing human androgen receptor (AR) with various lengths of 
polyglutamine stretches. Expression of human AR in the eye causes degeneration as 
long as they are raised on DHT containing food and degeneration is enhanced with 
increasing polyglutamine stretch (bottom row).  There is no significant effect on the 
eye when flies are raised on food lacking DHT (top row). Detailed genotypes in 
order: +/+; gmr gal4/+; uas-AR Q20, +/+; gmr gal4/+; uas-AR Q45, +/+; gmr 




Figure 2-2: Increase in polyglutamine stretch causes earlier onset of 
degeneration in the eye.   
SEM images of AR Q12, AR Q52 and AR Q121 expressing flies that were raised on 
regular food and aged on DHT containing food starting first day of adult life.  Fly 
heads were dissected and fixed on indicated ages.  First appearance of degeneration i  
AR Q121 expressing flies is by day 18 (bottom row), and of AR Q52 expressing flies 
is by day 28 (middle row), while no degeneration is observed in AR Q12 expressing 
flies (Genotype: +/+; gmr gal4/+; uas-AR Q12) by day 60, indicating that length of 
polyglutamine stretch determines age of onset of degeneration (Quantification of 
phenotypes done by Udai Pandey).   
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Genetic impairment of the proteasome results in activation of autophagy 
Previous studies have suggested that the proteasome is inhibited in 
neurodegeneration models (Lindsten, de Vrij et al. 2002).  Therefore, we 
hypothesized that proteasome impairment alone may lead to activation of autophagy 
since maintenance of catabolism is essential for cellular homeostasis.  DTS7 is 
temperature sensitive, dominant negative form of the β2 subunit of the proteasome 
(Belote and Fortier 2002).  When it is expressed in the eyes of the flies reared at 
22OC, eye morphology is normal (Figure 2-3A).  By contrast, when flies expressing 
DTS7 are reared at 28OC, there is a substantial degeneration in the eye (Figure 2-3B).  
When examined by TEM, autophagic vacuoles were rare or absent in the eyes of the 
flies reared at 22OC (data not shown).  However, there were numerous autophagic 
vacuoles in the retina of the flies expressing DTS7 reared at 28OC (Figure 2-3C).  
Among these were vacuoles that contained multi-vesicular bodies (Figure 2-3D), and 
organelles (Figure 2-3E), which both typically appear during autophagy.  This 
indicates that autophagy is activated beyond normal levels when the proteasome is 
inhibited.   
A genetic approach was used to test whether autophagy was cytotoxic or 
cytoprotective upon proteasome inhibition.  Downregulation of autophagy with atg6 
or atg12 RNAi in the eyes of the flies reared at 22OC did not result in a considerable 
change in the eye compared to DTS7 expression alone (Figure 2-4, top row).  
However, downregulation of autophagy with the same RNAi constructs in the eyes of 
the flies reared at 28OC, enhanced the degeneration seen with DTS7 expression alone 
(Figure 2-4, bottom row).  These results imply that upon proteasome inhibition, 
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activation of autophagy has a protective role, since impairing activation of autophagy 










Figure 2-3: Inhibition of the proteasome activates autophagy. 
Effect of expressing the temperature sensitive, dominant negative proteasome subunit 
in the eye (A, B).  uas-DTS7 expressing fly eyes are normal when they are reared at 
22oC (A), while they have rough eye phenotype when they are reared at 28oC (B), 
genotype: w; gmr-GAL4/+; uas-DTS7/+.  TEM images of retinal sections of DTS7 
expressing flies raised at 28oC show the appearance of autophagic vacuoles and 
multi-vesicular bodies (C and D respectively).  (E) shows high magnification of the 





Figure 2-4: Inhibition of autophagy enhances degeneration caused by 
proteasome impairment.   
(Top row) Downregulation of essential autophagy genes atg6 and atg12 by RNAi in 
DTS7 expressing animals does not have an effect on eye morphology at the 
permissive temperature 22oC.  (Bottom row) Eye degeneration seen in DTS7 is 
enhanced when autophagy is downregulated by atg6 and atg12 RNAi at restrictive 
temperature 28oC, indicating that inhibition of both the proteasome and autophagy 
cause enhanced toxicity than inhibiting only the proteasome or autophagy alone. 
Genotypes in order: w; gmr-GAL4/+; uas-DTS7/+, w; gmr-GAL4/uas-Atg6-IR; uas-
DTS7/+, uas-Atg12-IR/+; gmr-GAL4/+; uas-DTS7/+.     
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The Proteasome is inhibited in the SMBA model 
Inhibition of the proteasome has been implicated in a wide variety of 
neurodegenerative diseases (Bence, Sampat et al. 2001).  In order to study the 
proteasome in the fly SBMA model, we utilized transgenic flies expressing a 
fluorescent reporter of proteasome function.  CL1-GFP is a fusion between GFP and a 
short polypeptide that renders GFP a target for the proteasome (Dantuma, Lindsten et 
al. 2000).  Since this fusion protein is a target for the proteasome, it is degraded under 
normal conditions (Figure 2-5B).  However, when proteasome is impaired CL1-GFP 
is retained in the cell and is detectable by fluorescence microscopy.  We tested thi  in 
the eye imaginal discs of the third instar larvae by utilizing the temperatur  sensitive 
nature of the DTS7 transgene.  No CL1-GFP was detected in the eye imaginal discs 
of flies expressing DTS7 at 22OC.  By contrast, CL1-GFP is detected in flies 
expressing DTS7 at 28OC (Figure 2-5C, D).  This showed that the CL1-GFP fusion 
reporter can be reliably used to detect proteasome impairment.  We used this system 
to test whether the proteasome was inhibited in the SBMA model.  In the flies 
expressing AR with 121 glutamine repeats in the eye in the absence of DHT, CL1-
GFP was not detected.  By contrast, when the same flies were reared on food 
containing DHT, CL1-GFP was detected (Figure 2-5E, F).  This shows that in the fly





Figure 2-5: The proteasome is inhibited in flies expressing AR Q121 on DHT 
food.   
Confocal microscopy images of the proteasome reporter expressed in the imaginal 
eye discs from 3rd instar larvae. (A) GFP expression alone showing that GFP alone is 
not degraded.  (B) CL1-GFP expression alone, indicating that it is degraded in 
controls.  (C-F) CL1-GFP expression with indicated genotypes.  (C,D) CL1-GFP 
accumulation, indicating proteasome inhibition, is observed only at restrictive 
temperature when the dominant negative proteasome subunit (DTS7) is expressed.  
(E,F) CL1-GFP is accumulated only when AR Q121 expressing flies were raised on 
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DHT food, indicating that the proteasome is inhibited in the SBMA model.      
Genotypes: (A) w; gmr-GAL4/+; uas-GFP/+.  (B) w; gmr-GAL4/+; uas-CL1-
GFP/+.  (C) w; gmr-GAL4/+; uas-CL1-GFP/uas-DTS7.  (D) w; gmr-GAL4/+; uas-
CL1-GFP/uas-DTS7.  (E) w; gmr-GAL4/+; uas-CL1-GFP/ uas-AR Q121.  (F) w; 
















Role of autophagy in the SBMA model 
To determine the role of autophagy in the SBMA model, we tested the effect of 
autophagy downregulation.  Downregulation of autophagy by atg6 or atg12 RNAi in 
the eyes of flies expressing AR with 52 glutamine repeats did not result in a 
considerable change in the eye compared to expression of AR with 52 glutamine 
repeats alone (Figure 2-6, top row).  However, down-regulation of either atg6 or 
atg12 in the eyes of flies reared on DHT food enhanced eye degeneration in flies 
expressing AR with 52 glutamine repeats (Figure 2-6, bottom row).  These data 
indicate that in the fly SBMA model, autophagy protects the cell from polyglutamine-
expanded protein toxicity.   Furthermore, our data suggest that polyglutamine 
expression induces proteasome inhibition (Figure 2-5: The proteasome is inhibited in 
flies expressing AR Q121 on DHT food.  , and that autophagy may be induced to 
compensate for altered proteasome function.  If this is true, ectopic induction of 
autophagy under the conditions of proteasome inhibition should suppress 
degeneration.   
To investigate this possibility, we used the class I PI3 kinase pathway inhibitor, 
PTEN.  The class I PI3 kinase pathway positively regulates growth, and negatively 
regulates autophagy (Baehrecke 2005).  In the presence of DHT, co-expression of AR 
with 52 glutamine repeats and PTEN, suppressed the rough eye phenotype compared 
to the expression of AR with 52 repeats alone (Figure 2-7A,B and C).  This is due to 
activation of autophagy by PTEN, since, downregulation of autophagy in the same 
background by atg12 or atg6 RNAi restores the degenerative phenotype (Figure 2-7D 
and E).  In addition, the degenerative phenotype of AR with 52 glutamine repeats 
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expression was significantly decreased when flies were reared on food containing 
rapamycin (data not shown).  Rapamycin activates autophagy by inhibiting TOR, 
which is a downstream component of the PI3 kinase pathway (Scott, Schuldiner et al. 
2004).  These data imply that autophagy is activated in the SBMA model in order to 






Figure 2-6: Inhibition of autophagy enhances degeneration of the eye in the 
SBMA model.   
(Top row) Downregulation of essential autophagy genes atg6 and atg12 by RNAi has 
no effect on eye phenotype of 1 day old flies expressing AR Q52 reared on regular 
food.  (Bottom row) Eye degeneration seen in AR Q52 expressing 1 day old flies on 
DHT containing food is enhanced when autophagy is downregulated, suggesting that 
autophagy is protective in the SBMA model.  Genotypes in order: w; gmr-GAL4/+; 
uas-AR Q52/+, w; gmr-GAL4/uas-Atg6-IR; uas-AR Q52/+, uas-Atg12-IR/Y; gmr-




Figure 2-7: Activation of autophagy reduces degeneration in the eye expressing 
AR Q52.    
(A) AR Q52 expressing 1 day old flies reared on DHT food show eye degeneration.  
(B) PTEN expression alone in 1 day old flies reared on DHT food show no 
degeneration.  (C) PTEN and AR Q52 expressing 1 day old flies reared on DHT food 
indicates decreased eye degeneration compared to AR Q52 expression alone (A).  
This decrease is autophagy dependent, since down-regulation of autophagy genes by 
atg12 (D) and by atg6 RNAi (E) reverses the effect of ectopic PTEN expression on 
eye degeneration, seen when AR Q52 is expressed alone (A). Genotypes in detail: (A) 
w; gmr-GAL4/+; uas-AR Q52/+, (B) w; gmr-GAL4/+; uas-PTEN/+, (C) w; gmr-
GAL4/+; uas-AR Q52/uas-PTEN, (D) uas-Atg12-IR/Y; gmr-GAL4/+; uas-AR 








We tested the hypothesis that proteasome inhibition contributes to polyglutamine-
induced neurodegeneration.  The ubiquitin-proteasome system is the first line of 
defense against the accumulation of misfolded proteins.  It is one of the major 
catabolic processes that is involved in essential cellular functions as diverse as the 
cell cycle progression, modulation of cell surface receptors, and the immune system 
(Ciechanover, Orian et al. 2000).  In neurons, the proteasome contributes to 
specialized functions including axon pruning, and regulating the protein content of 
synapses (Patrick 2006).  The proteasome’s role to degrade misfolded proteins culd 
be critical for neurons since neurons are long-lived post mitotic cells that are likely to 
be more sensitive to accumulating cellular stress.  This could also explain why 
familial neurodegenerative diseases affect the nervous system exclusively, even 
though all tissues should carry the same mutation.  In this study, we have shown that 
proteasome inhibition by ectopic expression of DTS7 causes eye degeneration (Figure 
2-3).  Similarly, in an SBMA model created by ectopic expression of glutamine-
expanded AR, we observed eye degeneration (Figure 2-1).  Importantly, the 
proteasome is also impaired in the SBMA model (Figure 2-5).  The observation of 
eye degeneration by either inhibition of the proteasome alone or by the ectopic 
expression of mutant AR implies that proteasome impairment could contribute to the 
degeneration associated with the SBMA model.  How do polyglutamine expanded 
proteins inhibit the proteasome? Since the protein inclusions stain positive for the 
mutant protein and ubiquitin, the proteasome may attempt to degrade polyglutamine 
expanded proteins at first.  It’s been reported that the proteasome cannot degrade 
proteins with long glutamine stretches (Venkatraman, Wetzel et al. 2004).  Therefore, 
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mutant proteins may occupy the proteasome and this may lead to impairment.  
However, this subject is under debate (Michalik and Van Broeckhoven 2004).   
Autophagic structures have been associated with the nervous tissue in 
neurodegenerative diseases, while they are not easily detected in the nervous system 
under physiological conditions (Mizushima, Yamamoto et al. 2004).  Autophagy is 
one of the major catabolic systems in the eukaryotic cell.  Therefore, we can 
hypothesize that autophagy is induced in cells under protein stress to help degrade the 
misfolded proteins.  In this study we show that autophagy is induced when the 
proteasome is impaired by DTS7 expression alone (Figure 2-3), and the eye 
degeneration phenotype of DTS7 is enhanced when autophagy is impaired (Figure 
2-4).  In addition, the eye degeneration phenotype of DTS7 expression is rescued with 
induction of autophagy by rapamycin treatment (Pandey, Nie et al. 2007).  These data 
imply that induction of autophagy is sufficient to alleviate the toxic effects of 
proteasome impairment, probably by reducing protein stress.  This is important since 
it points to a possible relationship between the two catabolic pathways, and that 
autophagy could at least partially compensate for the ubiquitin proteasome system.  
Similar to proteasome inhibition alone, in the SBMA model the eye degeneration 
phenotype is enhanced when autophagy is impaired (Figure 2-6) and the degeneration 
phenotype is reduced when autophagy is activated by PTEN expression (Figure 2-7) 
or by rapamycin treatment (Pandey, Nie et al. 2007).  Collectively this data implies 
that the degenerative phenotype that is observed in the SBMA model is partially, if 
not entirely, due to proteasome impairment (Figure 2-5), and induction of autophagy 
helps clear the protein stress that ensues as a result of proteasome impairment (Figure 
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2-7).  Once induced, autophagy could be degrading either the small soluble protein 
oligomers, the contents of the protein inclusions, or both.  It has been suggested that 
the soluble oligomers are the toxic species perhaps due to their potential to impair the 
proteasome (Abel, Walcott et al. 2001).  It has also been suggested that inclusion 
formation may help degrade the toxic species in a neurodegenerative diseasemodel 
(Taylor, Tanaka et al. 2003).  Moreover, inclusion formation was found to be 
mediated by proteins like p62 (Bjorkoy, Lamark et al. 2005; Komatsu, Waguri et al. 
2007) and HDAC6 (Iwata, Riley et al. 2005), which are both associated with 
autophagy.  Finally, overexpression of HDAC6 ameliorates the degenerative 
phenotype of SBMA model that is shown here in an autophagy dependent manner 
(Pandey, Nie et al. 2007).  Collectively, these findings fit into a model in which 
misfolded proteins are first accumulated into inclusions with the activities of proteins 
like p62 and HDAC6, later these proteins help move the proteins in inclusions into 
the autophagic machinery for degradation.  HDAC6 fits this model since it is a 
cytoplasmic, microtubule associated protein that could be a part of a molecular motor 
involved in carrying cargo associated with this process (Kawaguchi, Kovacs et l. 
2003).   
It is not clear how proteasome impairment leads to toxicity in the context of 
neurodegenerative diseases.  We can speculate that an overwhelmed proteasome 
could lead to failure in many regulatory pathways that the proteasome controls, and 
this defect eventually results in cell death.  In the case of neurons, the dysfunctional 
cells cannot be replaced.  Therefore, it is likely that a dysfunctional neuron lives until 
it dies with cellular catastrophe.  The accumulation of numerous dysfunctional or 
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dying cells could eventually lead to symptoms observed in these diseases.  This might 
also contribute to the late onset nature of neurodegenerative diseases.  Our study 
implies that therapeutic treatments that increase levels of autophagy, like rapamycin 
treatment, could delay the disease progression.  However, it should be noted that 
autophagy has been implicated in cell death (Lee and Baehrecke 2001; Berry and 
Baehrecke 2007).   While low levels of autophagy are essential for physiological 
functions and cell survival, high levels of autophagy are detrimental to the cell 
(Baehrecke 2005; Berry and Baehrecke 2007; Scott, Juhasz et al. 2007).  A complete 
understanding of polyglutamine protein toxicity and development of therapeutic 
strategies will require deeper understanding of this disease and its relationship to 












Dynein light chain 1 is required for autophagy, protein 
clearance and cell death in Drosophila 
Abstract 
Autophagy is a conserved catabolic pathway that is important for turnover of 
long-lived proteins and organelles, and has been implicated in cell survival, tumor 
progression, protection from infection, neurodegenerative disease and cell death. 
Autophagy and caspases are required for type II autophagic cell death of Dros phila 
larval salivary glands during development, but the mechanisms that regulate these 
degradation pathways are not understood.  We conducted a forward genetic screen for 
genes that are required for salivary gland cell death, and here we describe the 
identification of Drosophila dynein light chain 1 (ddlc1) as a gene that is required for 
type II cell death with autophagy.  Autophagy is attenuated in d lc1 mutants, but 
caspases are active in these cells. ddlc1 mutant salivary glands develop large fibrillar 
protein inclusions that stain positive for amyloid-specific dyes and ubiquitin.  Ectopic 
expression of Atg1 is sufficient to induce autophagy, clear protein inclusions, and 
rescue degradation of ddlc1 mutant salivary glands.  Furthermore, ddlc1 mutant 
larvae have decreased motility, and mutations in ddlc1 enhance the impairment of 
motility that is observed in a Drosophila model of polyglutamine disease.  
Significantly, this decrease in larval motility is associated with the accumulation of 
p62 in muscles.  These results indicate that Ddlc1 is required for protein clearance by 




Macroautophagy (hereafter referred to as autophagy) is an evolutionarily 
conserved catabolic pathway (Mizushima, Noda et al. 1998; Xie and Klionsky 2007).  
Pioneering studies of yeast identified genes that are required for autophagy (atg 
genes) during starvation (Takeshige, Baba et al. 1992; Thumm, Egner et al. 1994; 
Klionsky and Emr 2000).  Autophagy is also activated during starvation in animals 
(Mizushima, Yamamoto et al. 2004), but the complexity of higher animals, and the 
association of autophagy with neurodegenerative diseases, bacterial clearance, 
antigen presentation, tumor suppression/survival and cell death (Mizushima 2005), 
raises questions about how autophagy is regulated and how cargo is recruited and 
delivered to lysosomes in multicellular organisms.  
Autophagy involves the formation of an isolation membrane around 
cytoplasmic components to form the autophagosome, and content of this structure is 
degraded by fusion with lysosomes (Klionsky and Emr 2000).  The formation of the 
isolation membrane requires the action of the Atg8 and the Atg12 conjugation 
pathways.  Atg12 is activated by Atg7 in an ATP dependent manner, and becomes 
conjugated with Atg5 and Atg16 through an Atg10 intermediate. Atg8 (LC3 in 
mammals) is cleaved by Atg4, and activated by Atg7 before it is conjugated to 
phosphatidylethanolamine (PE) through an Atg3 intermediate (Ohsumi 2001).  Atg8-
PE is a structural element of the autophagosomal membrane.  While much is known 
about the formation of autophagosomes, several important questions about the 
regulation of autophagy remain unanswered.  For example, it is not known whether 
cytoplasmic components are directed to the site of autophagosome formation, and it is 
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not completely clear how autophagosomes and lysosomes find each other to complete 
degradation.  Nevertheless, there is some evidence that autophagosome formation and 
proper movement and fusion with lysosomes depends on intact microtubules (Fass, 
Shvets et al. 2006; Kochl, Hu et al. 2006).  Moreover, autophagosome movement was 
shown to be dependent on dynein motor function since down regulation of the dynein 
intermediate chain or p150 disrupts autophagosome movement (Kimura, Noda et al. 
2008).    
The role of autophagy in programmed cell death has been a subject of debate 
(Baehrecke 2005; Levine and Yuan 2005). Autophagy has a well established role in 
survival, and decreased autophagy gene function can promote cell death (Boya, 
Gonzalez-Polo et al. 2005).  The association of autophagy with neurodegenerative 
diseases (Nixon, Wegiel et al. 2005) resulted in interest about the role of this
catabolic process in cell survival and death.  Autophagy plays a protective role 
against neurodegeneration in disease models (Bjorkoy, Lamark et al. 2005; Pandey, 
Nie et al. 2007; Boland, Kumar et al. 2008), as well as under physiological conditions 
(Hara, Nakamura et al. 2006; Komatsu, Waguri et al. 2006).  The role of autophagy in 
cell survival has also been demonstrated in cancer (Qu, Yu et al. 2003; Yue, Jin et al. 
2003).  In this case, rapidly growing tumors utilize autophagy degradation products as 
nutrients.  Alternatively, if degradation of cellular components reaches higher levels 
this may lead to cell death of cancer cells (Mathew, Karantza-Wadsworth et al. 2007).  
Autophagosomes have been associated with dying cells during development 
(Schweichel and Merker 1973; Clarke 1990), and recent studies indicate that 
autophagy can promote the degradation and clearance of cells during cell death 
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(Berry and Baehrecke 2007; Qu, Zou et al. 2007).  This apparent paradox raises 
questions about how autophagy is regulated in the context of cell death.  
Drosophila larval salivary glands possess type II cell death morphology 
during development, and contain numerous autophagosomes (Lee and Baehrecke 
2001; Martin and Baehrecke 2004; Berry and Baehrecke 2008).  A rise in the steroid 
20-hydroxyecdysone 12 hours after puparium formation triggers cell death, and 
glands are completely destroyed within 4 hours (Jiang, Baehrecke et al. 1997; Lee 
and Baehrecke 2001).  Salivary glands fail to completely degrade in atg mutants, and 
induction of autophagy by expression of Atg1 is sufficient to induce caspase-
independent cell death (Berry and Baehrecke 2008).  Caspases are also required for 
salivary gland degradation, and function in the fragmentation of DNA, cleavage of 
nuclear Lamins, and likely many other caspase substrates in these cells (Martin and 
Baehrecke 2004).  Inhibition of both caspases and autophagy has a stronger 
persistence phenotype than inhibiting either of these pathways alone, indicating th  
caspases and autophagy work in an additive manner to degrade salivary glands (Berry 
and Baehrecke 2008).  Therefore, larval salivary glands in Drosophila are degraded 
with a unique form of cell death that requires both caspases and autophagy.  
Dyneins are conserved microtubule dependent molecular motors involved in 
retrograde transport of cargo in the cell.  They are composed of heavy, intermediate, 
light intermediate and light chains.  Heavy chains regulate movement on microtubules 
in an ATP dependent fashion, while light chains are involved in cargo recognition 
(Vallee, Williams et al. 2004).  The smallest dynein light chain (LC8/PIN in 
vertebrates and Ddlc1/Cutup in Drosophila) encodes a 8kD protein that is highly 
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conserved from Chlamydomonas to humans (King, Barbarese et al. 1996).  LC8 binds 
to a variety of cargo as a dimer via a conserved motif (Lo, Naisbitt et al. 2001; 
Rodriguez-Crespo, Yelamos et al. 2001), including neuronal nitric oxide synthase 
(nNOS), inhibitor of NF-κB (IκBα), nuclear respiratory factor-1 (NRF-1), p53-
binding protein 1 (53BP1) and the estrogen receptor (ER) (Jaffrey and Snyder 1996; 
Crepieux, Kwon et al. 1997; Herzig, Andersson et al. 2000; Lo, Kan et al. 2005; 
Rayala, den Hollander et al. 2005).  In Drosophila, Ddlc1 is cytoplasmic and 
ubiquitously expressed. Complete loss of function of ddlc1 causes embryonic 
lethality and ectopic apoptosis (Dick, Ray et al. 1996).  Ectopic activation of 
apoptosis could be due to Ddlc1’s inhibitory effect on proapoptotic Bcl-2 family 
members, such as Bim as has been demonstrated in mammalian cells (Puthalakath, 
Huang et al. 1999).  Partial loss of function mutations in Drosophila ddlc1 cause 
female sterility and alter proper sensory neuron development with defects in axon 
guidance (Phillis, Statton et al. 1996).  Ddlc1’s crucial role in oogenesis ha  been 
demonstrated since it is required for proper localization of the swallow and gurken 
RNAs in the oocyte (Schnorrer, Bohmann et al. 2000; Wang, Hare et al. 2004; Rom, 
Faicevici et al. 2007).  
Here we characterize a ddlc1 mutant that was isolated in a forward genetic 
screen for genes that are required for salivary gland cell death in Drosophila.  We 
show that salivary glands of ddlc1 animals are defective in autophagy and fail to die 
normally.  The salivary gland cells that fail to die develop large amyloid-like protein 
inclusions that can be degraded by ectopic expression of Atg1, a regulator of 
autophagy.  Furthermore, we show that ddlc1 enhances motility defects in a model of 
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the polyglutamine neurodegenerative disease spinobulbar muscular atrophy, and 
suggest that this is because of the accumulation of protein aggregates in muscles.     
Materials and Methods 
Drosophila strains 
A collection of 1,475 single P element-lacZ insertion mutations were screened to 
identify genes that were expressed 13 hours after pupariation.  From this screen
l(1)G0371 was found as a P element-induced mutation of ddlc1 (also known as cutup, 
ctp).  The ddlc1 precise excision line was generated by crossing the l(1)G0371 line to 
∆ 2-3 transposase as described (Robertson, Preston et al. 1988) and precise excision 
was confirmed by DNA sequencing.  The uas-Ddlc1 strain was created as described 
below.  uas-p35 (Hay, Wolff et al. 1994) was used to inhibit effector caspases. uas-
Atg1GS10797 and uas-Atg16B (Scott, Juhasz et al. 2007) were used for ectopic induction 
of autophagy.  uas-Sgs3-GFP (Biyasheva, Do et al. 2001) was used to track the Glue 
protein in salivary glands.  Fkh-Gal4 (Berry and Baehrecke 2007) was used to drive 
salivary gland specific expression.  The uas-AR Q20 and uas-AR Q52 lines were used 
for the Spinal Bulbar Muscular Atrophy model (Pandey, Nie et al. 2007).  uas-GFP-
LC3 (Rusten, Lindmo et al. 2004) was used as a marker of autophagosomes, and 
tubulin-GFP-LAMP1 (courtesy of H. Krämer) was used as a marker of lysosomes.  






uas-Ddlc1 transgenic flies 
To create the uas-Ddlc1 rescue construct, the ddlc1 open reading frame (ORF) 
with flanking EcoRI and XbaI flanking restriction sites was amplified from the 
Berkeley Drosophila Genome Project cDNA library and cloned using the TA cloning 
kit (Invitrogen).  The ddlc1 ORF was sequenced, isolated from the TA vector by 
restriction digestion with EcoRI and XbaI, and inserted in the pUAST Drosophila 
transformation vector.  The uas-Ddlc1 construct was then used to generate transg nic 
Drosophila (Best Gene Inc. Chino Hills, CA).    
Salivary gland histology 
Animals of indicated genotypes were staged as new white prepupae and aged at 
25oC until either 2 hours or 12 hours after head eversion, fixed in FAAG overnight, 
dehydrated, embedded in paraffin, sectioned and stained with Weigert’s hematoxylin 
and Pollack’s Trichrome as previously described (Muro, Berry et al. 2006).  DNA 
fragmentation was detected by TUNEL assay using the Apoptotag kit (Chemicon) 
according to manufacturer’s protocols.  To detect amyloidosis with Thioflavin-S, 
paraffin sections were rehydrated, stained with Mayer’s Hematoxylin (Fluka Chemie, 
Switzerland) for 1 minute, stained with 1% Thioflavin-S (Sigma) for 5 minutes, 
followed by dehydration and mounting in Vectashield with DAPI (Vector 
Laboratories).  For Congo red staining, paraffin sections were rehydrated, stained 
with Mayer’s Hematoxylin for 1 minute, equilibrated in NaCl saturated 80% ethanol 
for 20 minutes, stained with 0.2% Congo Red (Sigma) in saturated NaCl solution for 
1 hour, and dehydrated.  Sections were examined with a Zeiss Axio Imager.Z1 
microscope.   
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Caspase substrate assays 
The EnzChek Caspase-3 Assay kit (Molecular Probes) was used according to 
manufacturer’s protocols.  Either Canton-S control, precise excision of the l(1)G0371 
P-element control or ddlc1 l(1)G0371 P-element mutant pupae were staged as new 
white prepupae, aged to 4 hours after puparium formation,  whole animal lysates were 
isolated and reaction buffer containing the Z-DEVD-AMC was added followed by 
incubation at 370C for 30 minutes. Fluorescence was detected by using a 
spectrometer. To confirm the specificity of the assay for measuring caspase-3-like 
activity, Ac-DEVD-CHO was added to Canton-S lysate as a competitive inhibitor. In 
addition, the pan-caspase inhibitor p35 was ubiquitously expressed by using the 
daughterless-GAL4 driver.  Each experiment was repeated three times.    
Fluorescence microscopy  
For autophagosome and lysosome detection using uas-GFP-LC3 and tub-GFP-
LAMP1, pupae were staged as new white prepupae, aged to either 6 hours after 
puparium formation, 2 hours or 12 hours after head eversion.  Salivary glands were 
dissected in PBS, stained with Hoechst 33342 to detect DNA, mounted in PBS, and 
immediately imaged with Zeiss Axio Imager.Z1 with Apotome.    The number of 
GFP-positive puncta was quantified using Ziess automatic measurement software.  
The value for each gland was calculated by the mean number of punctae from three 
fields of vision. 
Immunohistochemistry 
For immunohistochemistry, salivary glands were dissected from pupae 2 hours 
after head eversion, fixed in 4% paraformaldehyde and processed as previously 
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described (Martin and Baehrecke 2004).  Rabbit anti-Ref(2)P was used at 1:1000, 
mouse anti- mono- and poly-ubiquitinylated proteins (clone FK2, Biomol) was used 
at 1:500 concentrations.  For neuromuscular junction staining, third instar larvae were 
dipped in calcium free saline solution (128 mM NaCl, 2mM KCl, 4mM MgCl2-6H2O, 
35.5 mM Sucrose, 5 mM HEPES, 1mM EGTA), filleted open and cleared of non-
neuromuscular organs in a dissection dish and fixed in 4% paraformaldehyde for 10 
minutes.  The preparations were then washed with phosphate buffered triton-x100 
(0.2 %) solution and stained with anti-Ref(2)P as above.  Preparations were stained 
with secondary antibody and/or with anti-HRP conjugated antibody used at 1:200, 
and mounted in Vectashield medium with DAPI (Vector Laboratories, CA).  
Electron microscopy  
Freshly dissected salivary glands were fixed in 2.5% glutaraldehyde in 0.1M 
cacodylate buffer pH7.4, post-fixed in buffered 1% osmium tetroxide, dehydrated 
through a graded ethanol series and propylene oxide and infiltrated for embedding in 
SPI-pon/Araldite.  Ultrathin sections (80nm) were stained with uranyl acetate and 
lead citrate before examination in a Philips CM12 transmission electron microscope.   
Protein extracts and western blotting 
Salivary glands were dissected 1.5 hours after head eversion,  placed in Laemmli 
buffer (0.1% glycerol, 2% SDS, 0.125 M Tris [pH 6.8], 0.05% β-mercaptoethanol, 
and 0.05% bromophenol blue) and boiled for 5 minutes.  Equal amounts of total 
protein were separated on 12% SDS-polyacrylamide gels.  Separated proteins were 
transferred to 0.45 µm Immobilon-P membranes (Millipore).  Membranes were 
stripped with 25 mM glycine-HCL, pH 2, 15% SDS buffer between antibodies as 
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described by the manufacturer. Anti- Ref(2)P was used at 1: 5000, mouse anti- mono- 
and poly-ubiquitinylated proteins (clone FK2, Biomol) were used at 1:10,000 and 
anti-β-tubulin was used at 1:50 concentration.  
Larval motility assay 
15 wandering third instar larvae were collected from the indicated genotypes, 
washed in PBS and individually placed on a 1% agarose gel cast in an 80mm petri 
dish.  The petri dish was placed on gridlines spaced by 5 mm.  The larvae were 
allowed to acclimate for 1 minute, and then the number of grid lines that the posterior 
end of the larvae passed in 2 minutes was recorded for each larva.  The average 
number of grid lines passed was calculated for each experiment.  Each experimnt 
was repeated three times.  The average of three experiments is reported for each 
genotype.    
Results 
Dynein light chain 1 is required for salivary gland degradation 
Several genes, including steroid-regulated transcription factors, caspases, 
autophagy genes and regulators of growth, have been identified that are required for 
proper destruction of larval salivary glands (Baehrecke 2000; Neufeld and Baehrecke 
2008).  In addition, hundreds of genes are induced within 4 hours of salivary gland 
degradation (Lee, Clough et al. 2003), suggesting that many additional genes may 
function in the death of these cells.  To identify additional genes that function in 
salivary gland programmed cell death, we screened a collection of 1,475 stocks with a 
single lethal P-element-LacZ enhancer trap reporter for expression 13 hours after 
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puparium formation, and failure of salivary gland degradation at 24 hours after 
puparium formation.  From this screen, we identified the P-element line l(1)G0371 
inserted into the dynein light chain 1 gene ddlc1, also known as cutup (ctp).  The 
location of the P-element insertion was mapped to 124 bp downstream of the first 
exon.  This ddlc1 allele is pupal lethal and their head eversion occurs at 15 hours after 
puparium formation. 
Histological examination of ddlc1 mutant animals 12 hours after head eversion 
revealed a significant defect in salivary gland cell death.  All ddlc1 pupae failed to 
complete salivary gland degradation, with animals having either intact or partially 
fragmented glands (Figure 3-1B, C, F).  By contrast, most control animals lack 
salivary glands (Figure 3-1A, F).  Significantly, precise excision of the l(1)G0371 P-
element reverted the defect in salivary gland degradation (data not shown).  We 
confirmed the salivary gland cell death defect of ddlc1 by using a different allele 
(ddlc1e73), which was previously reported to have axon guidance defects (Phillis, 
Statton et al. 1996). 100% of ddlc1e73 animals failed to destroy their salivary glands 
by 12 hours after head eversion (data not shown).  To further confirm that the failur
in salivary gland degradation phenotype was caused by loss of ddlc1 function, we 
performed a transgenic rescue experiment (Brand and Perrimon 1993).  We generated 
transgenic flies and expressed Ddlc1 in the salivary glands of dlc1 mutant flies.  
Histological examination indicated that expression of Ddlc1 in salivary glands l rgely 
rescued the ddlc1 mutant defect in degradation of this tissue 24 hours after puparium 
formation (Figure 3-1D, E, F).  These data indicate that ddlc1 is necessary for 




Figure 3-1: Dynein light chain 1 is required for salivary gland degradation. 
(A-E) Representative paraffin sections of pupae 12 hours after head eversion.  (A) 
Almost all control animals lack salivary glands (n=16).  (B,C) All dd c1 mutant 
animals fail to degrade their salivary glands with some being intact (B) and others 
being fragmented (C) (n=28). (D, E) Expression of Ddlc1 in salivary glands largely 
rescues the degradation defect phenotype of ddlc1 mutants with a small number of 
animals having fragmented salivary glands (D) and most having none (E) (n=22).  
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(F) Percentage of animals with intact, fragmented and no salivary glands. ddlc1 
mutant pupae in black, rescue in gray, and control in white bars. Detailed genotypes: 


















ddlc1 mutants have altered caspase levels 
Ectopic caspase activity was previously shown to be present in Drosophila ddlc1 
mutants (Dick, Ray et al. 1996) and Ddlc1 inhibits the pro-apoptotic activity of Bim 
in mammalian cells (Puthalakath, Huang et al. 1999).  Since caspases are required to 
complete salivary gland cell degradation (Lee and Baehrecke 2001; Martin and 
Baehrecke 2004; Berry and Baehrecke 2008), we hypothesized that ddlc1 may 
regulate caspases in salivary glands.  Caspase-dependent DNA fragmentation was 
detected in both the control and the ddlc1 mutant salivary glands by the TUNEL 
assay 2 hours after head eversion (Figure 3-2A, B).  Even though ddlc1 mutant 
salivary glands fail to be degraded, they had premature DNA fragmentation before
the rise in steroid that triggers DNA fragmentation and cell death in wild-type 
salivary glands (data not shown).  Caspase activity levels were quantified using the 
fluoregenic caspase substrate DEVD-AMC.  Both wild-type and control animals 
lacking the P-element following precise excision had comparable levels of capase 
activity, and this activity could be inhibited by either a chemical inhibitor (Z-VAD-
FMK) or genetically by expression of the pan-caspase inhibitor p35 (Figure 3-2C) 
(Hay, Wolff et al. 1994; Lee and Baehrecke 2001; Martin and Baehrecke 2004; Berry 
and Baehrecke 2008). Although ddlc1 mutant animals have reduced caspase activity 
(Figure 3-2C), the presence of caspase activity and fragmented DNA suggests that 
residual cysteine protease activity may be the reason that salivary gland degradation 
is not completely inhibited in ddlc1 mutants.  
To test if caspases contribute to ddlc1 mutant salivary gland degradation, we 
expressed p35 in ddlc1 mutant salivary glands and examined them using paraffin 
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histology.  As previously shown (Lee and Baehrecke 2001; Berry and Baehrecke 
2007), all control animals that express p35 in salivary glands possess partly degrade  
condensed salivary gland cell fragments 24 hours after puparium formation (Figure 3-
2D).  In control ddlc1 mutants, 39% of animals have intact salivary glands, while 
61% are partly degraded (Figure 3-2D).  By contrast, p35 expression in the salivary 
glands of ddlc1 mutant animals results in nearly complete inhibition of degradation, 
with 96% of these animals having intact salivary glands.  These data indicate that 
caspases are active and contribute to the partial salivary gland degradation phenotype 
in ddlc1 mutant animals, and suggest that Ddlc1 influences non-caspase factor(s) that 













Figure 3-2: ddlc1 mutants have altered caspase levels. 
(A, B) TUNEL assay to detect DNA fragmentation in control (A) and ddlc1 mutant 
(B) salivary glands 2 hours after head eversion (AHE) (n=5/genotype).  (C) Caspase 
activity of pupal lysates collected at 4 hours after puparium formation (n=3) measured 
by cleavage of fluorogenic caspase-3 substrate Z-DEVD-AMC. The strains used for 
caspase activity measurements include WT: wild-type Canton S, WT + C.I.: wild-
type Canton S + caspase inhibitor DEVD-CHO, p35: daGAL4 x uas-p35, Ex: precise 
excision of the P element, ddlc1: ddlc1/Y.  (D) Percentage of animals of indicated 
genotypes with salivary gland cell fragments and intact salivary glnds. Graph 
represents quantification of persistent salivary glands in paraffin sections of pupae 12 
hours after head eversion.  Detailed genotypes: Control (fkhGAL4/+) white bar 
(n=16), p35 expression (fkhGAL4/uas-p35) gray bar (n=13), ddlc1 mutant (ddlc1/Y; 
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+/+; fkhGAL4/+) black bars (n=28), and p35 expression in ddlc1 mutant animals 
(ddlc1/Y; fkhGAL4/uas-p35), striped bars (n=24). Error bars in (C) represent standard 

















ddlc1 mutant glands have impaired autophagy 
Autophagosome formation and atg genes are induced just prior to salivary gland 
cell death, and autophagy is required for complete degradation of this tissue (Lee and 
Baehrecke 2001; Lee, Clough et al. 2003; Berry and Baehrecke 2007; Berry and 
Baehrecke 2008).  We tested whether autophagy is defective in ddlc1 mutant salivary 
glands by using the autophagosome marker GFP-LC3 (Rusten, Lindmo et al. 2004).  
As expected, the number of GFP-LC3 puncta increased in control salivary glands 
following the rise in steroid that triggers salivary gland cell death (Figure 3-3A, B, 
D).  By contrast, the number of GFP-LC3 puncta was significantly lower in ddlc1
mutant salivary glands at the same stage (Figure 3-3C, D).  In addition, the number of 
GFP-LC3 puncta did not increase in ddlc1 mutant salivary glands 10 hours later 
(Figure 3-3D).  These data indicate that ddlc1 mutant salivary glands are impaired in 
autophagosome formation.  
Since lysosomes are required for autophagy, we tested if lysosome numbers 
are altered in ddlc1 mutant salivary glands by expressing a GFP-Lysosome associated 
membrane protein 1 (LAMP1) reporter transgene (Rusten, Lindmo et al. 2004).  In 
controls, the number of GFP-LAMP1 puncta increases following the rise in steroid 
that triggers salivary gland cell death (Figure 3-3E, F, H).  Although the number of 
GFP-LAMP1 puncta was lower in ddlc1 mutant salivary glands at the same stage 
(Figure 3-3G, H), the number of GFP-LAMP1 puncta increases 10h later (Figure 3-
3H).  These data indicate that although lysosome numbers are reduced in ddlc1 
mutant salivary glands, lysosome biogenesis appears to occur in this tissue. 
Consistent with this conclusion, the endosome-associated marker GFP-Rab5 is 
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identical in ddlc1 mutant and wild-type salivary glands following the rise in steroid 
that triggers salivary gland cell death (data not shown). Taken together, thes data 
indicate that ddlc1 mutant salivary glands are defective in autophagosome biogenesis, 

















Figure 3-3: Autophagy is attenuated in ddlc1 mutants.  
(A-C) Representative fluorescence microscopy images of salivary glnds expressing 
GFP-LC3 (green) and DNA (blue).  (A) Control animal salivary glands have little to 
no puncta before cell death at 6 hours after puparium formation (APF) (n=16). (B) 
Control animal salivary glands have a large number of puncta 2 hours after head 
eversion (AHE) (n=20).  (C) ddlc1 mutant salivary glands have few puncta 2 hours 
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AHE (n=17). Detailed genotypes: (A, B) ex; +/+; fkhGAL4/uas-GFP-LC3, (C) 
ddlc1/Y; +/+; fkhGAL4/uas-GFP-LC3.  (D) Average number of GFP-LC3 puncta in 
the genotypes shown in A-C, and in ddlc1 mutant animals 12 hours AHE (n=23), 
detailed genotype: ddlc1/Y; +/+; fkhGAL4/uas-GFP-LC3. Error bars represent 
standard error. (E-G) Representative fluorescence microscopy images of salivary 
glands expressing GFP-LAMP1 (green) and DNA (blue).  (E) Control animals have 
little LAMP1 puncta 6 hours APF (n=19).  (F) Control animals have a large number 
of LAMP1 puncta 2 hours AHE (n=19).  (G) ddlc1 mutant glands have fewer LAMP1 
puncta than controls 2 hours AHE (n=25).  Detailed genotypes: (E, F) ex; tub-GFP-
LAMP1/+, (G) ddlc1/Y; tub-GFP-LAMP1/+.  (H) Average number of GFP-LAMP1 
puncta in the genotypes shown in (E-G), and in dlc1 mutant animals 12 hours AHE 
(n=21), detailed genotype: ddlc1/Y; tub-GFP-LAMP1/+.  Error bars represent 










ddlc1 mutants contain amyloid-like protein inclusions that can be degraded 
by induction of autophagy 
The observation of fewer autophagosomes in ddlc1 mutant salivary gland cells 
prompted us to investigate their morphology by transmission electron microscopy 
(TEM).  Wild-type salivary gland cells contain autophagosomes and autolysosmes 
that are typically observed in these cells following the rise in steroid that triggers their 
death (Figure 3-4A).  Although ddlc1 mutant salivary glands contained some 
autophagic structures, numerous fibrillar inclusions were present.  These inclusio s 
appear to be dispersed throughout the cytoplasm and were not surrounded by 
membranes (Figure 3-4B).  The Glue protein is produced and secreted by the salivary
glands to help pupae attach to surfaces during pupariation.   ddlc1 mutant animals can 
secrete the Glue protein normally (Figure 3-6).  Therefore, it is unlikely that these 
inclusions form due to aggregation of the Glue protein.  
The accumulation of protein inclusions is the most common outcome of 
neurodegenerative diseases (Ross and Poirier 2004).  Protein inclusion formation has 
been associated with proteasome inhibition (Bence, Sampat et al. 2001; Pandey, Nie 
et al. 2007).  Therefore, we tested if the proteasome was inhibited in the ddlc1 mutant 
salivary glands by expressing the GFP fused CL1 reporter (Dantuma, Lindsten et al. 
2000). GFP-CL1 is normally degraded by the proteasome, and if the proteasome is 
inhibited it accumulates in the cell and can be detected as a GFP signal.  Expression 
of GFP-CL1 alone and in the ddlc1 mutant background did not result in GFP-CL1 
accumulation in the gland (data not shown).  By contrast, inhibition of the proteasome 
by expressing a temperature sensitive dominant negative subunit of the proteasome 
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(Belote and Fortier 2002) resulted in GFP-CL1 accumulation (data not shown).  
These results suggest that the proteasome system is not inhibited in the dlc1 mutant 
salivary glands.  The fibrillar nature of the ddlc1 mutant salivary gland inclusions are 
similar to β-sheet structures that are observed in amyloids associated with 
neurodegenerative diseases (Ross and Poirier 2004).  Therefore, we tested ifhe 
protein inclusions in ddlc1 mutant salivary glands are similar to protein inclusions 
seen in neurodegenerative diseases by performing histological tests that are typically 
used to detect amyloidosis in the clinic (Maezawa, Hong et al. 2008).  Thioflavin-S 
stains of the ddlc1 mutant salivary gland paraffin sections contained numerous 
brightly-stained foci that are indicative of amyloids (Figure 3-4D), while control 
glands did not possess these structures (Figure 3-4C).  Similarly, congo-red staining 
of inclusions was only present in experimental ddlc1 mutant salivary glands (data not 
shown).   
Protein inclusions that are associated with neurodegeneration typically contain 
ubiquitin and p62, proteins that are associated with the ubiquitin proteasome system 
and autophagy (Ross and Pickart 2004; Bjorkoy, Lamark et al. 2005).  Therefore, we 
tested whether the protein inclusions that are observed in ddlc1 mutant salivary 
glands contain ubiquitin and Drosophila p62 ortholog Ref(2)P  (Nezis, Simonsen et 
al. 2008).  While both Ubiquitin and Ref(2)P were detected in wild-type salivary 
gland cells, they were not co-localized (Figure 3-4E).  By contrast, Ubiquitin and 
Ref(2)P were co-localized in large puncta in ddlc1 mutant salivary gland cells (Figure 
3-4F).  Furthermore, Ref(2)P levels were elevated and higher molecular weight 
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proteins were ubiquitinylated in ddlc1 mutant salivary glands compared to wild-type 
salivary glands (Figure 3-4G).  
Protein inclusions accumulate when catabolic pathways, including autophagy, 
are defective during neurodegeneration (Iwata, Riley et al. 2005; Pandey, Nie et al. 
2007; Pan, Kondo et al. 2008).  The reduced number of GFP-LC3 autophagosomes 
and accumulation of protein aggregates in ddlc1 mutant salivary glands (Figures 3-3 
and 3-4) prompted us to test if expression of the Atg1 kinase, a protein that is 
sufficient to induce autophagy (Berry and Baehrecke 2007; Scott, Juhasz et al. 2007), 
is sufficient to inhibit the accumulation of protein aggregates in these mutants.  
Significantly, the thioflavin-S positive inclusions in ddlc1 mutant salivary gland cells 
were absent when we expressed a moderate strength Atg1 transgene in this tissue 
(Scott, Juhasz et al. 2007) (Figure 3-4D, I).  In addition, TEM sections of these glands 
indicated that fibrillar inclusions were absent in glands with enhanced degradation 
(data not shown) or reduced in moderately degraded glands (Figure 3-4B, H).  
Therefore, since ddlc1 glands are defective in autophagosome formation (Figure 3-3), 
we propose that the cell death and protein inclusion defects in ddlc1 mutant salivary 








Figure 3-4: ddlc1 mutants contain amyloid-like protein inclusions that are 
reduced when autophagy is induced. 
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(A,B) TEM images of salivary glands. Bars represent 1µm. (A) Wild-type Canton S 
control salivary glands 2 hours AHE.  (B) ddlc1 mutant salivary glands 2 hours AHE 
possess numerous large fibrillar inclusions.  (C,D) Thioflavin-S-stained paraffin 
sections of pupae.  (C) Wild-type Canton S control salivary glands 2 hours AHE 
possess no Thioflavin-S-stained foci (n=10 animals).  (D) ddlc1 mutant salivary 
glands 2 hours AHE possess numerous bright green foci indicative of Thioflavin-S-
staining (n=10 animals).  (E,F) Immunohistochemistry images of salivary gl nds 2 
hours AHE, Ref(2)P (green), Ubiquitin (red), DNA (blue).  (E) Wild type Canton S 
control salivary gland showing no co-localization of Ref(2)P and Ubiquitin 2 hours 
AHE.  (F) ddlc1 mutant salivary glands contain large puncta with co-localization of 
Ref(2)P and Ubiquitin 2 hours AHE.  (G) Ref(2)P and Ubiquitin immuno-blot of 
salivary glands isolated from control and ddlc1 mutant animals 2 hours AHE. Tubulin 
is a control for loading and transfer.  (H, I) Expression of Atg1 in ddlc1 mutant 
salivary glands 2 hours AHE.  (H) TEM image of gland showing attenuation of 
fibrillar inclusions (compare with B), bar represents 1µm.  (I) Thioflavin-S-stained 
paraffin sections contain little or no foci in salivary glands (compare with D) (n=10), 








ddlc1 enhances motility defects in a Spinal Bulbar Muscular Atrophy model 
We have previously shown that protein clearance by autophagy plays an 
important role in an eye model of the neurodegenerative disorder spinal bulbar 
muscular atrophy (SBMA) (Pandey, Nie et al. 2007).  SBMA is characterized by 
progressive muscular atrophy in males, and is caused by polyglutamine expansion in 
the androgen receptor (AR) in the presence of  the AR ligand testosterone (Takeyam , 
Ito et al. 2002).  Similar to our previous studies in a Drosophila eye model, we 
observed a polyglutamine length- and ligand-dependent decrease in motor activity
when we expressed AR in motor neurons of third instar larvae (Figure 3-5A).  In 
addition, ddlc1 mutant larvae possess motility defects, and loss of ddlc1 enhances the 
SBMA defect in motor activity when expanded polyglutamine-containing AR is 
expressed in motor neurons (Figure 3-5B).  
Significantly, ddlc1 mutant larval muscles have numerous p62 positive inclusions 
(Figure 3-5G), while wild type larval muscles have a diffuse staining of p62 (Figure 
3-5F).  In addition, these inclusions become larger when AR Q52 is expressed in the 
presence of DHT (Figure 3-5H).  Moreover, ddlc1 mutants and dlc1 mutants 
expressing AR Q52 with DHT occasionally have punctate Ref(2)P staining pattern in 
their motor neurons (Figure 3-5D, E), and wild type motor neurons do not (Figure 3-
5C).  Ref(2)P positive inclusions were previously observed in cases where catabolism 
was compromised as discussed above.  Therefore, these data suggest that the motor 
activity defect of ddlc1 larvae could be due to catabolic defects in the neuromuscular 
tissue.  Enlargement of Ref(2)P positive inclusions (Figure 3-5H) and enhancement of 
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motility defect in ddlc1 mutants (Figure 3-5B)  indicates that expressing AR Q52 












Figure 3-5: ddlc1 enhances motility defects in a model of Spinal Bulbar Muscular 
Atrophy, and this phenotype is associated with Ref(2)P inclusions in axons and 
muscles. 
(A,B) Average number of grid lines passed by the posterior end of larvae.  (A) The 
motility of either wild-type Canton S larvae (+/+), or larvae expressing full-length 
human androgen receptor in motor neurons containing 20 glutamines (AR Q20) or 52 
glutamines (AR Q52) and raised on food containing dihydrotestosterone (DHT) were 
analyzed (n=3 x15 larvae).  (B) ddlc1/Y mutant larvae have motility defects compared 
to control female siblings (ddlc1/+), and the motility defect of AR 52Q expression is 
enhanced when it is expressed in ddlc1 mutant larvae in the presence of DHT (n=3 x 
15 larvae). “*” indicates a p< 0.01 significant difference, “**” indicates a p< 0.001 
significant difference from wild-type (+/+ or ddcl1/+ controls). “***” indicates a p< 
0.001 significant difference of AR Q52 expression alone from the AR Q52 expression 
in the ddlc1 mutant larvae.  Detailed genotypes in order within graphs: (A) 
d42GAL4/+, w; uas-hAR- Q20/d42GAL4, w; uas-hAR Q52/d42GAL4. (B) ddlc1/+ ♀ 
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, ddlc1/Y, w; uas-hAR Q52/d42GAL4, ddlc1/Y; uas-hAR Q52/d42GAL4. (C-E) 
Ref(2)P staining (green) in third instar larval motor neurons.  (C) Wild-type Canton S 
control showing no punctate staining (n=6 animals).  (D) ddlc1 mutant neurons 
contain Ref(2)P positive punctate staining (n=4).  (E) ddlc1 mutant expressing hAR 
Q52 in the presence of DHT showing Ref(2)P positive punctate staining (n=4 
animals).  (F-H) Ref(2)P staining (green) of third instar larval muscles.  (F) Wild-type 
Canton S control muscles contain little or no punctate Ref(2)P staining (n=6).  (G) 
ddlc1 mutant larval muscles contain Ref(2)P positive punctate staining (n=4).  (H) 
ddlc1 mutant larvae expressing hAR Q52 in the presence of DHT have large Ref(2)P 










Figure 3-6: ddlc1 salivary glands are not defective in secretion of the Glue 
protein 
(A) Control larva with salivary glands filled with the GFP-tagged Glue protein.  (B) 
Control white pre-pupa after secretion of the Glue protein.  Some Glue protein is 
observed attached to the cuticle and none is in the salivary glands.  (C) ddlc1/Y larva 
with salivary glands filled with the GFP-tagged Glue protein.  (D) ddlc1/Y white pre-
pupa after secretion of the Glue protein showing that the ddlc1 mutation does not 








Drosophila ddlc1 was identified in a forward genetic screen for genes that are 
required for type II cell death with autophagy in salivary glands (Figure 3-1).  Ddlc1 
has been implicated in the regulation of cell death through physical interactions w th 
Bim (Puthalakath, Huang et al. 1999) and p53 binding protein (Lo, Kan et al. 2005).   
Both of these cases imply that Ddlc1 functions in cell death by influencing the 
activity of caspase regulators and caspases.  By contrast, we found that d lc1 mutant 
animals possess caspase activity that is only slightly lower than controls, and our 
genetic studies indicate that factors other than caspases are influenced by ddlc1, and 
required for salivary gland destruction (Figure 3-2). Significantly, ddlc1 mutant 
salivary glands are defective in autophagosome formation even though they assemble 
new lysosomes (Figure 3-3).  Thus, failure in salivary gland degradation is expect d, 
since degradation of this tissue requires autophagy (Lee and Baehrecke 2001; Berry 
and Baehrecke 2007).  Although autophagy is an important regulator of salivary 
gland cell death, we cannot exclude the possibility that ddlc1 regulates other 
processes that are required for destruction of this tissue.  In support of this possibility, 
ddlc1 mutant salivary glands have a stronger defect in their degradation than 
autophagy atg gene mutants (Berry and Baehrecke 2007). 
Ddlc1 is best known as a dynein motor component, but it also functions in motor-
independent processes (Barbar 2008).  For example, Ddlc1 and Bim influence 
caspase activity and cell death in a dynein motor-independent manner, by Ddlc1 
binding to and restriction of Bim pro-apoptotic activity (Puthalakath, Huang et al. 
1999).  Alternatively, Ddlc1 is part of a dynein motor in its regulation of the p53 
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binding protein and DNA damage-induced p53 nuclear localization (Lo, Kan et al. 
2005).  It is not completely clear how Ddlc1 regulates autophagy and salivary gland 
destruction.  An intact microtubule network is necessary for proper autophagy (Fass, 
Shvets et al. 2006; Kochl, Hu et al. 2006) and disruption of dynactin impairs 
autophagy (Kimura, Noda et al. 2008), so it is possible that Ddlc1 is part of a dynein 
motor that is required for autophagy in salivary glands.   However, we did not 
observe any defect in salivary gland degradation in Dynein heavy chain mutants (data 
not shown), and this suggests that Ddlc1 may be regulating autophagy in a motor-
independent manner.   Expression of the autophagy regulator Atg1 was sufficient to 
rescue salivary gland degradation (Figure 3-4). This suggests that Ddlc1 may either 
influence signaling upstream of Atg1.  Alternatively, Ddlc1 may facilitate the 
localization of either autophagosomal cargo or autophagy regulatory factors that are 
needed to form autophagosomes.  Future work should resolve these possible models 
for Ddlc1 function in dying salivary glands.   
The clearance of unwanted and damaged proteins is an essential component of 
cell homeostasis, and autophagy is one of the critical pathways for removal of such 
proteins (Klionsky and Emr 2000; Hara, Nakamura et al. 2006; Komatsu, Waguri et 
al. 2006).  Significantly, defects in protein clearance have been associated with 
several neurodegenerative disorders (Bjorkoy, Lamark et al. 2005; Pandey, Nie et al. 
2007; Boland, Kumar et al. 2008).  To our surprise, protein inclusions accumulate in 
ddlc1 mutant non-neuronal salivary glands (Figure 3-4).  The fibrillar nature of these 
inclusions is extremely reminiscent of β-sheet structures that are observed in neuronal 
amyloids, and staining with amyloid specific thioflavin-s supports this observation 
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(Figure 3-4).  We speculate that this protein inclusions form because of attenuated 
autophagy in ddlc1 mutants and this conclusion is supported by the fact that 
activation of autophagy by expression of Atg1 reduces these inclusions (Figure 3-4).  
In addition, the levels of p62 increased and were localized with ubiquitin positive 
inclusions in ddcl1 mutant salivary glands (Figure 3-4).   
p62 and ubiquitin accumulate in aging brain of conditional autophagy 
deficient mice and in flies (Komatsu, Waguri et al. 2007; Nezis, Simonsen et al. 
2008).  In addition, p62-associated protein inclusions were degraded by autophagy in 
a model of Huntington’s disease (Bjorkoy, Lamark et al. 2005), and disruption of the 
LC3/Atg8 binding domain in p62 resulted in the formation of ubiquitin-positive 
inclusions (Ichimura, Kumanomidou et al. 2008).  These and other studies suggest 
similarities between the role of autophagy in neuronal protein aggregation disorders 
and in ddlc1 mutant salivary glands, and this prompted us to study the influence of 
ddlc1 mutations on the nervous system.  We studied the influence of decreased Ddlc1 
function, as well as a model of the polyglutamine disorder SBMA, on larval 
locomotor activity.  Both ddlc1 mutant larvae and the SBMA model larvae exhibited 
decreased motor activity (Figure 3-5).  In addition, we observed that expression of 
AR Q52 in the motor neurons of ddlc1 mutant larvae enhanced motility defect and the 
size of p62-positive inclusions in muscles.  This observation suggests that the 
increased size of protein inclusions in ddlc1 muscle is triggered in a cell non-
autonomous manner by altered motor neuron function.  This phenomenon can be 
explained by interdependency of muscles and axons.  Axon growth and innervation is 
dependent on neurotrophic growth factors produced by muscles (Howe and Mobley 
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2005).  Likewise, formation of proper muscle structure requires signaling input from 
the innerving neurons (Maggs, Huxley et al. 2008).  Significantly, in a C. elegans 
model of polyglutamine disease, mutations in axonal GABAergic or cholinergic 
signaling disrupted protein homeostasis in the muscle causing enhanced 
polyglutamine inclusion formation and motility defects (Garcia, Casanueva et al. 
2007).  Moreover, these mutations caused temperature sensitive proteins to go into 
inclusions in the muscle at permissive temperatures.   Therefore, we speculate that 
AR Q52 expression in the motor neurons might cause signaling imbalance in the 
neurons that further negatively impacts protein homeostasis in the muscle of dd c1 
larvae.  It should be noted that we did not observe p62 positive inclusions in the 
muscles of larvae expressing AR Q52 in the motor neurons alone (data not shown).  
These observations suggest that ddlc1 mutation increases the propensity of protein 
stress and inclusion formation in the larval muscle perhaps due to Ddlc1’s 
involvement in protein degradation.  Accordingly, when AR Q52 is expressed in the 
motor neurons in ddlc1 background there is a higher likelihood to form protein 
inclusions (Figure 3-5).  
Autophagy is a catabolic process that clears material from the cytoplasm to 
promote physiological processes associated with organism, tissue and cell 
homeostasis.  Here we identify ddlc1 as a factor that is required for autophagy in 
dying cells, and show that loss of ddlc1 leads to accumulation of p62-associated 
aggregates in the non-neuronal salivary gland and muscle cell types.  These result  
raise the question of why these tissues exhibit ddlc1 mutant defects.  Larval salivary 
glands and muscles have several common features, including that they are made of
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endo-replicating cells that do not divide, they have very large cells with extensive 
cytoplasm, and that they die after larval development with a type II autophagic cell 
death morphology.  Therefore, one possibility is that these non-dividing cells rely 
more heavily on autophagy for clearance of either unwanted or damaged proteins than 
diploid cells, and that decreased autophagy leads to protein aggregates.  Alternatively, 
these are relatively long-lived cells, and it is possible that at stages approaching death 
autophagy increasingly promotes clearance of cytoplasm.  Therefore, impairment of 
autophagy results in protein accumulation at the time of cell death.  Future studies
should resolve how Ddlc1 functions in the regulation of protein clearance, autophagy 











Summary and Future Directions 
The relationship between the proteasome and autophagy in 
neurodegenerative disease 
The balance between anabolic and catabolic processes is crucial to maintain 
cellular homeostasis.  The ubiquitin-proteasome system and autophagy are the two 
main catabolic degradation systems.  The proteasome system is well studied, and it is
known to be a key regulator of many cellular activities (Ciechanover, Orian et l. 
2000; Glickman and Ciechanover 2002).  By contrast, autophagy is poorly 
understood.  Autophagy has been implicated in roles as diverse as turnover of 
organelles and long lived proteins, cell survival, cell death, neurodegenerative 
diseases and cancer (Klionsky and Emr 2000; Mizushima 2005).  It is possible that 
the proteasome system and autophagy communicate to maintain the appropriate 
quantity of catabolic degradation.  The discovery of the HDAC6 and p62 proteins that 
are associated with polyubiquitinylated proteins and autophagy raised the question 
whether these proteins link the proteasome and autophagy (Bjorkoy, Lamark et al. 
2005; Iwata, Riley et al. 2005).  Our studies indicate that when the proteasome is 
inhibited in-vivo, autophagy is induced to compensate for lack of degradation and to 
maintain homeostasis (Chapter 2).  Moreover in the SBMA neurodegenerative 
disease model used in this study, proteasome inhibition is compensated for by 
autophagy (Chapter 2).  HDAC6 appears to play a role in the autophagic degradation 
of proteins that were targeted to the proteasome but could not be degraded by this 
mechanism.  It has been suggested that HDAC6 could be part of a molecular motor 
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that moves cargo to inclusions, which are later degraded by autophagy (Kawaguchi, 
Kovacs et al. 2003).  This hypothesis is supported by our studies which show that 
autophagic rescue of degeneration in the eye is dependent on HDAC6 (Pandey, Nie et 
al. 2007).  However, the precise mechanism as to how the proteasome and the 
autophagy communicate, and HDAC6’s role in this communication, is not entirely 
understood.  It is of interest to investigate the binding partners of HDAC6 by yeast 
two hybrid screens, as well as by co-immunoprecipitation and proteomic analyses, in 
conditions of proteasome impairment.  HDAC6 may be found to bind to molecular 
motors and to proteins that could be causing proteasome impairment, such as 
polyglutamine expanded proteins.  It would also be interesting to investigate if 
proteasome inhibition is a prerequisite for the induction of autophagy during protein 
stress, or if accumulation of unwanted proteins alone induces autophagy.  Monitoring 
autophagy and proteasome levels during protein mis-expression may help us 
understand these possibilities and the relationship between proteasome inhibition and 
autophagy.   
Our results suggest that the induction of autophagy is protective against the 
degenerative effects of polyglutamine expanded AR expression (Chapter 2).  It should
be noted that we have not directly tested whether polyglutamine expanded AR causes 
protein stress, or alternatively if stress is caused by the accumulation of other 
proteins.  However, we know that turnover of polyglutamine expanded AR is 
significantly reduced in degenerative conditions (Pandey, Nie et al. 2007).  Either 
direct inhibition of the proteasome using a genetic approach, or indirect inhibition of 
the proteasome by the expression of polyglutamine expanded AR causes eye 
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degeneration (Chapter 2).  Therefore, the basis of toxicity in the SBMA model is th  
proteasome impairment.  This has important consequences for polyglutamine 
expansion diseases.  In patients, progressive proteasome inhibition is likely to be an 
important contributor to toxicity, and the reason for protein inclusion formation.  
However, this alone cannot explain the mechanism of all polyglutamine expansion 
diseases since different diseases have different symptoms and they affect different 
neurons.  This implies that either the natural function of the glutamine expanded 
protein or new functions it acquires might be involved in the outcomes of particular 
diseases.  Investigating the changes in gene and protein expression profiles in the 
SBMA model in the absence and presence of DHT could provide directions for 
deciphering the disease mechanisms in addition to proteasome inhibition.  Therapies 
that involve relieving the effects of proteasome inhibition, such as increasing the rate 
of autophagy, could delay the occurrence of symptoms.  However, this is complicated 
by the side effect of activating autophagy in tissues that are not involved in 
neurodegenerative symptoms, and that ectopic autophagy could induce cell death 
(Baehrecke 2005; Scott, Juhasz et al. 2007).  Another approach for therapy could be 
to screen known chemicals for their ability to upregulate HDAC6’s activity, since we 
have shown that overexpression of HDAC6 alone is enough to reduce the eye 
degeneration phenotype (Pandey, Nie et al. 2007).            
Autophagy in catabolism and cell death 
Larval salivary glands die in an autophagy- and caspase-dependent manner during 
development of Drosophila (Lee and Baehrecke 2001; Berry and Baehrecke 2007).  
We identified Ddlc1 as one of the effectors of salivary gland cell death in a forwrd 
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genetic screen (Chapter 3).  ddlc1 mutants were previously reported to have ovarian 
development and axon path finding defects (Dick, Ray et al. 1996).  ddlc1 mutant 
salivary glands were defective in autophagy, and as a result they had a considerable 
cell death defect (Chapter 3).  The complete mechanism of autophagy is not entirely
understood (Klionsky 2005).  For example, it is not known how autophagosomes 
form and are directed to lysosomes in the cytoplasm.  Our data indicate that Ddlc1 is 
involved in autophagosome formation (Chapter 3).  However, we could not identify 
the mechanism of Ddlc1’s contribution to autophagosomes.  Since ectopic expression 
of Atg1 could activate autophagy in ddlc1 mutants, Ddlc1 is likely to be involved in 
an upstream, yet unidentified regulation of autophagy.  We were limited in our ability
to do immunohistochemical analyses of ddlc1 mutant glands due to unavailability of a 
working antibody.  In the future, either Ddlc1 antibodies or Ddlc1 fused to a 
fluorescent protein could be generated to follow this protein in the cell (as long as this
fusion protein does not inhibit Ddlc1 function).  If Ddlc1 is co-localized with LC3 or 
Atg1 and not with lysosomes, this would support Ddlc1’s function in earlier steps of 
autophagosome formation.  Ddlc1 could also be immunoprecipitated to identify 
binding partners.  Dynein motor binding partners would confirm Ddlc1’s involvement 
in a dynein motor.  We speculated that Ddlc1 could be involved in bringing cargo to 
autophagosomes (Chapter 3).  This could be tested in cell lines or yeast in which 
autophagosomal cargo can be traced (Xie, Nair et al. 2008).  For example, this cargo 
may not be found in autophagosomes in ddlc1 mutants.          
We observed amyloid like inclusions in the ddlc1 mutant salivary glands (Chapter 
3).  Our data suggest that this is due to defects in autophagic degradation, as the 
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proteasome was not inhibited (data not shown).   Ref(2)P/p62, which functions in 
protein inclusion formation during protein stress (Bjorkoy, Lamark et al. 2005; 
Komatsu, Waguri et al. 2007; Nezis, Simonsen et al. 2008), was increased in ddlc1 
glands.  It is of interest to investigate if ddlc1 and ref(2)p double mutants could still 
form protein inclusions in the salivary gland.  If inclusions cannot form, this will 
confirm Ref(2)P’s function in inclusion formation in this tissue.  Moreover, it is of 
interest to determine the protein species that accumulate in inclusions.  Our data 
suggested that only a few ubiquitinylated species were upregulated in the ddcl1 
glands (Chapter 3).  These or other proteins that are upregulated in coomassie stained 
protein gels could be isolated and identified by mass spectrometry.  A considerable 
amount of glue protein is produced and secreted during pupariation to enable pupae to 
attach to surfaces (Biyasheva, Do et al. 2001).  Our data suggest that ddlc1 glands are 
not defective in secreting the glue protein (Chapter 3).  Therefore, it is unlikely that it
is the glue protein that aggregates in ddlc1 glands.    
To conclude, our studies illustrate the importance of compensatory autophagic 
degradation in neurodegenerative diseases.  In addition, impairment of autophagy 
through a mutation in ddlc1 caused inclusion formation that was reminiscent of 
neurodegenerative disease in non-neuronal salivary gland cells.  These observations 
are in agreement with the protein stress hypothesis of neurodegenerative diseases, 
which proposes that impairment of catabolic degradation causes protein stress and 
inclusions.  Emergence of autophagy as a protective mechanism in neurodegenerative 
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